nct_id,brief_title,sponsor_name,phases,has_results,overall_status,primary_completion_date,study_first_post_date,url,clean_primary_completion_date,is_phase4
NCT03235479,Safety and Efficacy Study in Adult Subjects With Acute Migraines,Pfizer,['PHASE3'],True,COMPLETED,2018-01-21,2017-08-01,https://clinicaltrials.gov/study/NCT03235479,2018-01-21,0
NCT02515279,An Observational Study of Peginterferon Alfa-2a Plus Ribavirin for Hepatitis C Virus (HCV) Infection in Austria,Hoffmann-La Roche,Unknown,True,COMPLETED,2014-12,2015-08-04,https://clinicaltrials.gov/study/NCT02515279,2014-12-01,0
NCT01294579,Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL),Novartis Pharmaceuticals,['PHASE2'],True,COMPLETED,2016-12-20,2011-02-11,https://clinicaltrials.gov/study/NCT01294579,2016-12-20,0
NCT05193279,Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age,Clover Biopharmaceuticals AUS Pty Ltd,"['PHASE2', 'PHASE3']",False,WITHDRAWN,2022-12-15,2022-01-14,https://clinicaltrials.gov/study/NCT05193279,2022-12-15,0
NCT03284879,Post-Marketing Surveillance Study of OTEZLA,Amgen,Unknown,False,COMPLETED,2021-10-31,2017-09-15,https://clinicaltrials.gov/study/NCT03284879,2021-10-31,0
NCT03630679,"A Study Evaluating Sleep, Stress and Infant Nutrition Using a Chatbot","Danone Asia Pacific Holdings Pte, Ltd.",Unknown,True,COMPLETED,2019-03-01,2018-08-15,https://clinicaltrials.gov/study/NCT03630679,2019-03-01,0
NCT06368479,Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings,bioLytical Laboratories,['NA'],False,ACTIVE_NOT_RECRUITING,2024-05-07,2024-04-16,https://clinicaltrials.gov/study/NCT06368479,2024-05-07,0
NCT06091579,"A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants",Insmed Incorporated,['PHASE1'],False,COMPLETED,2021-01-12,2023-10-19,https://clinicaltrials.gov/study/NCT06091579,2021-01-12,0
NCT06355479,A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia,Healthgen Biotechnology Corp.,['PHASE3'],False,COMPLETED,2023-11-22,2024-04-09,https://clinicaltrials.gov/study/NCT06355479,2023-11-22,0
NCT03777579,A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC,"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.",['PHASE3'],False,SUSPENDED,2019-12-30,2018-12-17,https://clinicaltrials.gov/study/NCT03777579,2019-12-30,0
NCT06351579,Data Collection Post Radical Prostatectomy,"Levee Medical, Inc.",Unknown,False,NOT_YET_RECRUITING,2025-12-30,2024-04-08,https://clinicaltrials.gov/study/NCT06351579,2025-12-30,0
NCT06671379,"A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC","Suzhou Suncadia Biopharmaceuticals Co., Ltd.",['PHASE3'],False,NOT_YET_RECRUITING,2026-12,2024-11-04,https://clinicaltrials.gov/study/NCT06671379,2026-12-01,0
NCT05433779,Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients -2,Neosense Technologies,['NA'],False,TERMINATED,2023-06-16,2022-06-27,https://clinicaltrials.gov/study/NCT05433779,2023-06-16,0
NCT03565679,SpO2 Accuracy Comparison of Medline ReNewal Sensors to Arterial Blood CO-Oximetry,Medline Industries,['NA'],True,COMPLETED,2018-05-10,2018-06-21,https://clinicaltrials.gov/study/NCT03565679,2018-05-10,0
NCT05943379,RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects,"RemeGen Co., Ltd.",['PHASE2'],False,RECRUITING,2025-12-01,2023-07-13,https://clinicaltrials.gov/study/NCT05943379,2025-12-01,0
NCT06108479,Study of DF6215 in Patients With Advanced Solid Tumors,Dragonfly Therapeutics,['PHASE1'],False,RECRUITING,2025-09,2023-10-31,https://clinicaltrials.gov/study/NCT06108479,2025-09-01,0
NCT06101979,A Prospective Study of Fortiva in Hernia Repair,RTI Surgical,Unknown,False,ENROLLING_BY_INVITATION,2027-12,2023-10-26,https://clinicaltrials.gov/study/NCT06101979,2027-12-01,0
NCT04861779,A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies,"Haisco Pharmaceutical Group Co., Ltd.",['PHASE1'],False,UNKNOWN,2023-08,2021-04-27,https://clinicaltrials.gov/study/NCT04861779,2023-08-01,0
NCT01756079,A Study to Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105),Merck Sharp & Dohme LLC,['PHASE4'],True,COMPLETED,2015-11-17,2012-12-24,https://clinicaltrials.gov/study/NCT01756079,2015-11-17,1
NCT03434379,A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma,Hoffmann-La Roche,['PHASE3'],True,COMPLETED,2020-08-31,2018-02-15,https://clinicaltrials.gov/study/NCT03434379,2020-08-31,0
NCT02870179,Oxitone Sp02 Hypoxia Test Versus Reference Pulse Oximetry,Oxitone Medical Ltd.,Unknown,False,COMPLETED,2016-09,2016-08-17,https://clinicaltrials.gov/study/NCT02870179,2016-09-01,0
NCT05409079,Schulze Muscular Dystrophy Ability Clinical Study,AbiliTech Medical Inc.,['NA'],False,RECRUITING,2023-06-30,2022-06-08,https://clinicaltrials.gov/study/NCT05409079,2023-06-30,0
NCT02408679,Predictive Questionnaire for Vitamin D Insufficiency in Healthy Adults,Lesieur,Unknown,False,COMPLETED,2015-02,2015-04-03,https://clinicaltrials.gov/study/NCT02408679,2015-02-01,0
NCT01606579,Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies,"Prism Pharma Co., Ltd.","['PHASE1', 'PHASE2']",False,COMPLETED,2016-12-30,2012-05-25,https://clinicaltrials.gov/study/NCT01606579,2016-12-30,0
NCT03806179,Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL,Nordic Nanovector,['PHASE1'],True,COMPLETED,2022-08-08,2019-01-16,https://clinicaltrials.gov/study/NCT03806179,2022-08-08,0
NCT04722679,A Study to Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.,Bayer,Unknown,False,COMPLETED,2021-12-31,2021-01-25,https://clinicaltrials.gov/study/NCT04722679,2021-12-31,0
NCT05002179,Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections,A. Vogel AG,['PHASE4'],False,COMPLETED,2021-05-29,2021-08-12,https://clinicaltrials.gov/study/NCT05002179,2021-05-29,1
NCT05796479,A PK Comparability Study of Two Different Amlitelimab Drug Products in Healthy Participants,Sanofi,['PHASE1'],False,COMPLETED,2023-05-22,2023-04-03,https://clinicaltrials.gov/study/NCT05796479,2023-05-22,0
NCT04287179,SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes,Novo Nordisk A/S,['PHASE3'],False,WITHDRAWN,2020-11-16,2020-02-27,https://clinicaltrials.gov/study/NCT04287179,2020-11-16,0
NCT05585879,Demonstrating Effective Salvage of Inadequate Colonoscopies,Motus GI Medical Technologies Ltd,['NA'],False,TERMINATED,2024-04-26,2022-10-19,https://clinicaltrials.gov/study/NCT05585879,2024-04-26,0
NCT03131479,"Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.",Novartis Pharmaceuticals,['PHASE2'],True,COMPLETED,2018-01-16,2017-04-27,https://clinicaltrials.gov/study/NCT03131479,2018-01-16,0
NCT06166979,Colonisation of Scalp by Topical Probiotic Micrococcus Luteus Q24,BLIS Technologies Limited,['NA'],False,NOT_YET_RECRUITING,2024-02-25,2023-12-12,https://clinicaltrials.gov/study/NCT06166979,2024-02-25,0
NCT02738879,Randomized Sitagliptin Withdrawal Study (MK-0431-845),Merck Sharp & Dohme LLC,['PHASE3'],True,COMPLETED,2018-01-22,2016-04-14,https://clinicaltrials.gov/study/NCT02738879,2018-01-22,0
NCT06558279,A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults with Ocular Myasthenia Gravis,argenx,['PHASE3'],False,RECRUITING,2025-12,2024-08-16,https://clinicaltrials.gov/study/NCT06558279,2025-12-01,0
NCT04071379,Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B,PT Bio Farma,['PHASE3'],False,COMPLETED,2021-04-06,2019-08-28,https://clinicaltrials.gov/study/NCT04071379,2021-04-06,0
NCT05882279,A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan,Takeda,Unknown,True,COMPLETED,2023-06-09,2023-05-31,https://clinicaltrials.gov/study/NCT05882279,2023-06-09,0
NCT05485779,"SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects",AQILION AB,['PHASE1'],False,COMPLETED,2023-07-10,2022-08-03,https://clinicaltrials.gov/study/NCT05485779,2023-07-10,0
NCT05263479,A Study of HS-20089 in Patients With Advanced Solid Tumors,"Shanghai Hansoh Biomedical Co., Ltd",['PHASE1'],False,RECRUITING,2024-12-31,2022-03-02,https://clinicaltrials.gov/study/NCT05263479,2024-12-31,0
NCT05904379,AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer,Akeso,"['PHASE1', 'PHASE2']",False,RECRUITING,2025-04-15,2023-06-15,https://clinicaltrials.gov/study/NCT05904379,2025-04-15,0
NCT04408079,"A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets","Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",['PHASE1'],False,UNKNOWN,2022-07-31,2020-05-29,https://clinicaltrials.gov/study/NCT04408079,2022-07-31,0
NCT01073579,Sabril Patient Registry,Lundbeck LLC,Unknown,False,COMPLETED,2016-07,2010-02-23,https://clinicaltrials.gov/study/NCT01073579,2016-07-01,0
NCT06602479,A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine,AstraZeneca,['PHASE2'],False,RECRUITING,2026-09-07,2024-09-19,https://clinicaltrials.gov/study/NCT06602479,2026-09-07,0
NCT03521479,"A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis","Squarex, LLC",['PHASE2'],True,TERMINATED,2018-10-05,2018-05-11,https://clinicaltrials.gov/study/NCT03521479,2018-10-05,0
NCT04734379,Rho Kinase (ROCK) Inhibitor in Tauopathies - 1,Woolsey Pharmaceuticals,['PHASE2'],False,UNKNOWN,2022-11-30,2021-02-02,https://clinicaltrials.gov/study/NCT04734379,2022-11-30,0
NCT03865979,AI ENRICH - AI Detection of ICH,"Viz.ai, Inc.",['NA'],False,COMPLETED,2023-03-15,2019-03-07,https://clinicaltrials.gov/study/NCT03865979,2023-03-15,0
NCT06411379,Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa,MoonLake Immunotherapeutics AG,['PHASE3'],False,RECRUITING,2025-06-17,2024-05-13,https://clinicaltrials.gov/study/NCT06411379,2025-06-17,0
NCT04365179,"Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML",Immune System Key Ltd,['PHASE1'],False,RECRUITING,2025-06-30,2020-04-28,https://clinicaltrials.gov/study/NCT04365179,2025-06-30,0
NCT03781479,Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients,"Catalyst Pharmaceuticals, Inc.",['PHASE2'],True,COMPLETED,2020-07-23,2018-12-20,https://clinicaltrials.gov/study/NCT03781479,2020-07-23,0
NCT04691479,Adherence and Quality of Life of CPAP for Obstructive Sleep Apnea,Air Liquide Healthcare Spain,['NA'],False,COMPLETED,2018-09-11,2020-12-31,https://clinicaltrials.gov/study/NCT04691479,2018-09-11,0
NCT02655679,An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis,"Vitae Pharmaceuticals, Inc.","['PHASE1', 'PHASE2']",True,COMPLETED,2016-09-09,2016-01-14,https://clinicaltrials.gov/study/NCT02655679,2016-09-09,0
NCT03982979,MOMENTUM 3 Pivotal Cohort Extended Follow-up PAS,Abbott Medical Devices,Unknown,False,COMPLETED,2021-09-08,2019-06-12,https://clinicaltrials.gov/study/NCT03982979,2021-09-08,0
NCT02698579,Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product,bluebird bio,Unknown,False,ACTIVE_NOT_RECRUITING,2038-08,2016-03-03,https://clinicaltrials.gov/study/NCT02698579,2038-08-01,0
NCT01254279,Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen,Sanofi,['PHASE3'],False,COMPLETED,2014-12,2010-12-06,https://clinicaltrials.gov/study/NCT01254279,2014-12-01,0
NCT04853979,Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure,Hamad Medical Corporation,['NA'],False,COMPLETED,2021-07-12,2021-04-22,https://clinicaltrials.gov/study/NCT04853979,2021-07-12,0
NCT04925479,Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia,Novartis Pharmaceuticals,"['PHASE1', 'PHASE2']",False,RECRUITING,2026-06-30,2021-06-14,https://clinicaltrials.gov/study/NCT04925479,2026-06-30,0
NCT03897179,INVSENSOR00032 and INVSENSOR00033 Respiration Rate Clinical Performance Study,Masimo Corporation,['NA'],True,COMPLETED,2019-02-25,2019-04-01,https://clinicaltrials.gov/study/NCT03897179,2019-02-25,0
NCT04551079,"A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics (PK) of Oral TAK-994 in an Acute Sleep Phase Delay Paradigm in Healthy Male Participants",Takeda,['PHASE1'],False,COMPLETED,2020-12-31,2020-09-16,https://clinicaltrials.gov/study/NCT04551079,2020-12-31,0
NCT03436979,The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse,Pop Medical Solutions,Unknown,False,ACTIVE_NOT_RECRUITING,2023-10-30,2018-02-19,https://clinicaltrials.gov/study/NCT03436979,2023-10-30,0
NCT01636479,Phase 1 Safety Testing of SAR405838,Sanofi,['PHASE1'],False,COMPLETED,2018-03-05,2012-07-10,https://clinicaltrials.gov/study/NCT01636479,2018-03-05,0
NCT05927779,Study of TFX06 in Women With Advanced Breast Cancer.,"Shenzhen Yangli Pharmaceutical Technology Co., Ltd","['PHASE1', 'PHASE2']",False,RECRUITING,2024-12-30,2023-07-03,https://clinicaltrials.gov/study/NCT05927779,2024-12-30,0
NCT03980379,"Pharmacokinetics, Efficacy and Safety of the 304 Injection","Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.",['PHASE1'],False,UNKNOWN,2019-06-30,2019-06-10,https://clinicaltrials.gov/study/NCT03980379,2019-06-30,0
NCT05683379,AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD,REGENXBIO Inc.,Unknown,False,RECRUITING,2024-12,2023-01-13,https://clinicaltrials.gov/study/NCT05683379,2024-12-01,0
NCT02914379,A Study of LY3337641 in Healthy Male Participants,Eli Lilly and Company,['PHASE1'],True,COMPLETED,2016-11,2016-09-26,https://clinicaltrials.gov/study/NCT02914379,2016-11-01,0
NCT03221179,"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7049665 in Healthy Volunteers",Hoffmann-La Roche,['PHASE1'],False,COMPLETED,2019-07-05,2017-07-18,https://clinicaltrials.gov/study/NCT03221179,2019-07-05,0
NCT02612779,A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.,Bristol-Myers Squibb,['PHASE2'],True,COMPLETED,2019-07-29,2015-11-24,https://clinicaltrials.gov/study/NCT02612779,2019-07-29,0
NCT05372679,REDUCED 1 - Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study /,SoniVie Inc.,['NA'],False,ACTIVE_NOT_RECRUITING,2025-12,2022-05-13,https://clinicaltrials.gov/study/NCT05372679,2025-12-01,0
NCT02477579,"A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions",Nitiloop Ltd.,['NA'],False,COMPLETED,2017-08-10,2015-06-23,https://clinicaltrials.gov/study/NCT02477579,2017-08-10,0
NCT06295679,A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease,Amgen,Unknown,False,RECRUITING,2028-12-19,2024-03-06,https://clinicaltrials.gov/study/NCT06295679,2028-12-19,0
NCT02302079,A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME),Astellas Pharma Europe B.V.,['PHASE2'],False,COMPLETED,2016-08-12,2014-11-26,https://clinicaltrials.gov/study/NCT02302079,2016-08-12,0
NCT04626479,Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A),Merck Sharp & Dohme LLC,"['PHASE1', 'PHASE2']",False,ACTIVE_NOT_RECRUITING,2026-05-31,2020-11-12,https://clinicaltrials.gov/study/NCT04626479,2026-05-31,0
NCT06025279,Musculoskeletal System Ultrasound Examination Data Collection Study for the Development of an Artificial Intelligence Software,Smart Alfa Teknoloji San. ve Tic. A.S.,Unknown,False,COMPLETED,2023-11-29,2023-09-06,https://clinicaltrials.gov/study/NCT06025279,2023-11-29,0
NCT03901079,Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions,Boston Scientific Corporation,Unknown,True,TERMINATED,2020-01-10,2019-04-03,https://clinicaltrials.gov/study/NCT03901079,2020-01-10,0
NCT01589679,"Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial","Dynasplint Systems, Inc.",['NA'],False,TERMINATED,2016-05,2012-05-02,https://clinicaltrials.gov/study/NCT01589679,2016-05-01,0
NCT03635879,Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides,Cerecin,['PHASE1'],False,WITHDRAWN,2019-04-16,2018-08-17,https://clinicaltrials.gov/study/NCT03635879,2019-04-16,0
NCT05542979,"A Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Virus Infection",Huahui Health,['PHASE1'],False,COMPLETED,2022-03-15,2022-09-16,https://clinicaltrials.gov/study/NCT05542979,2022-03-15,0
NCT02195479,A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma,"Janssen Research & Development, LLC",['PHASE3'],True,COMPLETED,2017-11-21,2014-07-21,https://clinicaltrials.gov/study/NCT02195479,2017-11-21,0
NCT05223179,Intramuscular CodaVax-H1N1 in Healthy Adults,"Codagenix, Inc",['PHASE1'],False,COMPLETED,2024-02-09,2022-02-03,https://clinicaltrials.gov/study/NCT05223179,2024-02-09,0
NCT06447779,"Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older",MAXVAX Biotechnology Limited Liability Company,['PHASE3'],False,ACTIVE_NOT_RECRUITING,2025-09,2024-06-07,https://clinicaltrials.gov/study/NCT06447779,2025-09-01,0
NCT03326479,POA Retrospective Repository,"Caris Science, Inc.",Unknown,False,UNKNOWN,2023-01-01,2017-10-31,https://clinicaltrials.gov/study/NCT03326479,2023-01-01,0
NCT02543879,Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies,"Forma Therapeutics, Inc.",['PHASE1'],False,COMPLETED,2019-03,2015-09-07,https://clinicaltrials.gov/study/NCT02543879,2019-03-01,0
NCT04604379,A Study to Review Treatment Outcomes From Treatment With Dysport® Injections in Adults for Upper and/or Lower Limb Focal Spasticity,Ipsen,Unknown,False,COMPLETED,2021-05-28,2020-10-27,https://clinicaltrials.gov/study/NCT04604379,2021-05-28,0
NCT04097379,"Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA",Novartis Pharmaceuticals,['PHASE2'],False,ACTIVE_NOT_RECRUITING,2024-08-08,2019-09-20,https://clinicaltrials.gov/study/NCT04097379,2024-08-08,0
NCT03355079,Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer Therapy,Fresenius Kabi,['PHASE4'],False,TERMINATED,2019-04-05,2017-11-28,https://clinicaltrials.gov/study/NCT03355079,2019-04-05,1
NCT02387879,"A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TR",Celgene,Unknown,False,UNKNOWN,2021-12-31,2015-03-13,https://clinicaltrials.gov/study/NCT02387879,2021-12-31,0
NCT04435379,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,Vakzine Projekt Management GmbH,['PHASE3'],False,COMPLETED,2021-10-12,2020-06-17,https://clinicaltrials.gov/study/NCT04435379,2021-10-12,0
NCT05667779,"A Study Evaluating Safety, Tolerability, and Pharmacokinetics of QRL-101 in Healthy Participants",QurAlis Corporation,['PHASE1'],False,COMPLETED,2023-12-27,2022-12-29,https://clinicaltrials.gov/study/NCT05667779,2023-12-27,0
NCT02963779,A Study of LY2775240 in Healthy Participants,Eli Lilly and Company,['PHASE1'],False,COMPLETED,2017-10-05,2016-11-15,https://clinicaltrials.gov/study/NCT02963779,2017-10-05,0
NCT03920579,A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers,Chong Kun Dang Pharmaceutical,['PHASE1'],False,UNKNOWN,2019-05,2019-04-19,https://clinicaltrials.gov/study/NCT03920579,2019-05-01,0
NCT05481879,"Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1",Dyne Therapeutics,"['PHASE1', 'PHASE2']",False,RECRUITING,2026-07,2022-08-01,https://clinicaltrials.gov/study/NCT05481879,2026-07-01,0
NCT03130179,A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.,McNeil AB,['PHASE1'],False,COMPLETED,2017-06-19,2017-04-26,https://clinicaltrials.gov/study/NCT03130179,2017-06-19,0
NCT04587479,A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors,"Jacobio Pharmaceuticals Co., Ltd.",['PHASE1'],False,UNKNOWN,2022-04-30,2020-10-14,https://clinicaltrials.gov/study/NCT04587479,2022-04-30,0
NCT00658879,Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan,Pfizer,Unknown,True,COMPLETED,2016-11-09,2008-04-15,https://clinicaltrials.gov/study/NCT00658879,2016-11-09,0
NCT04190979,Clinical Application of the Medyria TrackCath System in Endovascular Repair of Abdominal Aortic Aneurysms (AAA),Medyria AG,['NA'],False,COMPLETED,2019-02-25,2019-12-09,https://clinicaltrials.gov/study/NCT04190979,2019-02-25,0
NCT03748979,"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy",Takeda,['PHASE1'],True,COMPLETED,2019-10-24,2018-11-21,https://clinicaltrials.gov/study/NCT03748979,2019-10-24,0
NCT05853679,Regular Antibacterial Photodynamic Therapy on Oral Hygiene in Elderly Residents,Koite Health Oy,['NA'],False,COMPLETED,2023-04-18,2023-05-11,https://clinicaltrials.gov/study/NCT05853679,2023-04-18,0
NCT04865679,Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends,Axogen Corporation,['NA'],False,RECRUITING,2026-12,2021-04-29,https://clinicaltrials.gov/study/NCT04865679,2026-12-01,0
NCT04159779,A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece,AbbVie,Unknown,False,ACTIVE_NOT_RECRUITING,2026-06-30,2019-11-12,https://clinicaltrials.gov/study/NCT04159779,2026-06-30,0
NCT02493179,Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery,Hayat Pharmaceutical Co. PLC,['PHASE4'],False,UNKNOWN,2016-01,2015-07-09,https://clinicaltrials.gov/study/NCT02493179,2016-01-01,1
NCT04812379,Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP),"Otsuka Pharmaceutical Co., Ltd.",Unknown,False,ACTIVE_NOT_RECRUITING,2023-09-13,2021-03-23,https://clinicaltrials.gov/study/NCT04812379,2023-09-13,0
NCT06469879,A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",['PHASE3'],False,NOT_YET_RECRUITING,2026-09,2024-06-24,https://clinicaltrials.gov/study/NCT06469879,2026-09-01,0
NCT05823779,A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects,Global Research Institute,Unknown,False,RECRUITING,2024-12-31,2023-04-21,https://clinicaltrials.gov/study/NCT05823779,2024-12-31,0
NCT06642779,Comparative Analysis of the Visual Performance and Patient Satisfaction After Cataract Surgery With Implantation of a Medicontur Monofocal (877PAY) or a Medicontur Extended Depth of Focus (877PEY) IOL,Medicontur Medical Engineering Ltd,Unknown,False,COMPLETED,2023-11-21,2024-10-15,https://clinicaltrials.gov/study/NCT06642779,2023-11-21,0
NCT02946879,Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65),MeiraGTx UK II Ltd,Unknown,False,COMPLETED,2023-07,2016-10-27,https://clinicaltrials.gov/study/NCT02946879,2023-07-01,0
NCT05463679,"Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.","Aytu BioPharma, Inc.",['PHASE3'],False,SUSPENDED,2025-06,2022-07-19,https://clinicaltrials.gov/study/NCT05463679,2025-06-01,0
NCT05216679,Novel Stretching Device Versus Night Splints,SAE Orthopedics,['NA'],False,UNKNOWN,2022-09-01,2022-01-31,https://clinicaltrials.gov/study/NCT05216679,2022-09-01,0
NCT02771379,Post Authorisation Safety Study With Raxone in LHON Patients,Santhera Pharmaceuticals,Unknown,False,COMPLETED,2021-04-16,2016-05-13,https://clinicaltrials.gov/study/NCT02771379,2021-04-16,0
NCT05012579,Transcutaneous Afferent Patterned Stimulation (TAPS) for Reduction of Parkinson's Disease (PD) Related Action Tremor,"Cala Health, Inc.",['NA'],True,COMPLETED,2021-03-12,2021-08-19,https://clinicaltrials.gov/study/NCT05012579,2021-03-12,0
NCT03711279,A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma,"Jiangsu HengRui Medicine Co., Ltd.",['PHASE2'],True,TERMINATED,2021-06-21,2018-10-18,https://clinicaltrials.gov/study/NCT03711279,2021-06-21,0
NCT01263379,Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa,"Abeona Therapeutics, Inc","['PHASE1', 'PHASE2']",True,COMPLETED,2022-03-09,2010-12-20,https://clinicaltrials.gov/study/NCT01263379,2022-03-09,0
NCT04188379,A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).,argenx,['PHASE3'],False,COMPLETED,2022-02-03,2019-12-05,https://clinicaltrials.gov/study/NCT04188379,2022-02-03,0
NCT03304379,Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip,Regeneron Pharmaceuticals,['PHASE3'],True,COMPLETED,2019-12-13,2017-10-09,https://clinicaltrials.gov/study/NCT03304379,2019-12-13,0
NCT01324479,Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors,Novartis Pharmaceuticals,['PHASE1'],False,COMPLETED,2017-07-04,2011-03-29,https://clinicaltrials.gov/study/NCT01324479,2017-07-04,0
NCT04955379,Study in Pediatric Volunteers of a Handheld Device Versus a Standard Diagnostic Device in Ophthalmic Refraction,EyeQue Corp.,['NA'],False,RECRUITING,2023-07-31,2021-07-08,https://clinicaltrials.gov/study/NCT04955379,2023-07-31,0
NCT03759379,HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis),Alnylam Pharmaceuticals,['PHASE3'],True,ACTIVE_NOT_RECRUITING,2020-11-10,2018-11-30,https://clinicaltrials.gov/study/NCT03759379,2020-11-10,0
NCT04960579,P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma,"Poseida Therapeutics, Inc.",['PHASE1'],False,RECRUITING,2027-12,2021-07-14,https://clinicaltrials.gov/study/NCT04960579,2027-12-01,0
NCT02953379,Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis,EMS,['PHASE3'],False,WITHDRAWN,2019-12,2016-11-02,https://clinicaltrials.gov/study/NCT02953379,2019-12-01,0
NCT06684379,Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Prevention of COVID-19-Associated Cytokine Storm,PEACHES BIOTECH,"['PHASE1', 'PHASE2']",False,RECRUITING,2026-10-02,2024-11-12,https://clinicaltrials.gov/study/NCT06684379,2026-10-02,0
NCT06212479,An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.,Hercules,Unknown,False,RECRUITING,2034-01,2024-01-18,https://clinicaltrials.gov/study/NCT06212479,2034-01-01,0
NCT05779579,Study of HS-10517 in Chinese Adult Participants,"Jiangsu Hansoh Pharmaceutical Co., Ltd.","['PHASE1', 'PHASE2']",False,RECRUITING,2023-05-31,2023-03-22,https://clinicaltrials.gov/study/NCT05779579,2023-05-31,0
NCT01555879,Real-world Clinical Efficacy of Abatacept in the T3 Data Registry,Arthritis Northwest PLLC,Unknown,False,COMPLETED,2016-11,2012-03-16,https://clinicaltrials.gov/study/NCT01555879,2016-11-01,0
NCT05123079,Relative Bioavailability and Food Effect Following Single Oral Dose of Darigabat Tablet Formulations in Healthy Participants,"Cerevel Therapeutics, LLC",['PHASE1'],False,COMPLETED,2021-11-21,2021-11-17,https://clinicaltrials.gov/study/NCT05123079,2021-11-21,0
NCT01904279,A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA),Hoffmann-La Roche,['PHASE1'],True,COMPLETED,2016-05,2013-07-22,https://clinicaltrials.gov/study/NCT01904279,2016-05-01,0
NCT03238079,Study of PlasmaCap IG in Adults and Children With PIDD,Therapure Biopharma Inc,['PHASE3'],False,UNKNOWN,2020-08-25,2017-08-03,https://clinicaltrials.gov/study/NCT03238079,2020-08-25,0
NCT06473779,Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.,AstraZeneca,['PHASE3'],False,RECRUITING,2027-06-30,2024-06-25,https://clinicaltrials.gov/study/NCT06473779,2027-06-30,0
NCT05051579,A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities,Eli Lilly and Company,['PHASE2'],True,COMPLETED,2022-08-25,2021-09-21,https://clinicaltrials.gov/study/NCT05051579,2022-08-25,0
NCT03921879,Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma,"Oncotartis, Inc.",['PHASE1'],False,UNKNOWN,2021-04,2019-04-19,https://clinicaltrials.gov/study/NCT03921879,2021-04-01,0
NCT01723579,Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017),Organon and Co,['PHASE3'],False,WITHDRAWN,2015-05,2012-11-08,https://clinicaltrials.gov/study/NCT01723579,2015-05-01,0
NCT02344979,The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC,"Shenyang Sunshine Pharmaceutical Co., LTD.",Unknown,False,UNKNOWN,2015-06,2015-01-26,https://clinicaltrials.gov/study/NCT02344979,2015-06-01,0
NCT01264679,A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease,"AMAG Pharmaceuticals, Inc.",['PHASE3'],True,TERMINATED,2015-04-24,2010-12-22,https://clinicaltrials.gov/study/NCT01264679,2015-04-24,0
NCT04795479,T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers,Corcept Therapeutics,['PHASE1'],False,COMPLETED,2021-05-17,2021-03-12,https://clinicaltrials.gov/study/NCT04795479,2021-05-17,0
NCT02684279,Dasotraline Binge Eating Disorder Extension Study,"Sumitomo Pharma America, Inc.",['PHASE3'],True,COMPLETED,2019-06-24,2016-02-17,https://clinicaltrials.gov/study/NCT02684279,2019-06-24,0
NCT06316479,Safety and Performance of PTMC Dermal Filler,Aqpha Medical B.V.,['NA'],False,NOT_YET_RECRUITING,2024-12,2024-03-18,https://clinicaltrials.gov/study/NCT06316479,2024-12-01,0
NCT04770779,A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT),"Agios Pharmaceuticals, Inc.",['PHASE3'],False,ACTIVE_NOT_RECRUITING,2024-04-11,2021-02-25,https://clinicaltrials.gov/study/NCT04770779,2024-04-11,0
NCT04963179,PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.,Womed,['NA'],False,ACTIVE_NOT_RECRUITING,2023-11-11,2021-07-15,https://clinicaltrials.gov/study/NCT04963179,2023-11-11,0
NCT03618979,A Trial Comparing Three Orthobiologic Therapies on Atrophied Multifidus Muscles in Patients With Low Back Pain,"Regenexx, LLC",['NA'],False,TERMINATED,2022-06-29,2018-08-07,https://clinicaltrials.gov/study/NCT03618979,2022-06-29,0
NCT05003479,"Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)","Shenzhen Kangtai Biological Products Co., LTD",['PHASE1'],False,UNKNOWN,2022-09,2021-08-12,https://clinicaltrials.gov/study/NCT05003479,2022-09-01,0
NCT02582879,informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia,Pharmacyclics LLC.,Unknown,False,COMPLETED,2021-07-21,2015-10-21,https://clinicaltrials.gov/study/NCT02582879,2021-07-21,0
NCT03898479,Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata,Concert Pharmaceuticals,"['PHASE2', 'PHASE3']",False,ACTIVE_NOT_RECRUITING,2025-05,2019-04-02,https://clinicaltrials.gov/study/NCT03898479,2025-05-01,0
NCT06148779,Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care,Joint Academy,Unknown,False,RECRUITING,2025-06-30,2023-11-28,https://clinicaltrials.gov/study/NCT06148779,2025-06-30,0
NCT06590779,Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss,Cosmetique Active International,['NA'],False,NOT_YET_RECRUITING,2025-12-02,2024-09-19,https://clinicaltrials.gov/study/NCT06590779,2025-12-02,0
NCT02071979,Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds,"Arteriocyte, Inc.",['NA'],False,TERMINATED,2018-01,2014-02-26,https://clinicaltrials.gov/study/NCT02071979,2018-01-01,0
NCT01770379,Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.,Novartis Pharmaceuticals,['PHASE3'],True,TERMINATED,2015-05,2013-01-17,https://clinicaltrials.gov/study/NCT01770379,2015-05-01,0
NCT05515679,The BRAIN App: Building Relationships Using Artificial Intelligence and Nostalgia,Hopeful Aging,['NA'],True,COMPLETED,2022-12-15,2022-08-25,https://clinicaltrials.gov/study/NCT05515679,2022-12-15,0
NCT00966979,Triathlon® Partial Knee Replacement (PKR) Outcomes Study,Stryker Orthopaedics,['NA'],True,TERMINATED,2022-09,2009-08-27,https://clinicaltrials.gov/study/NCT00966979,2022-09-01,0
NCT06021379,AryoTrust® (Trastuzumab) Safety Study,AryoGen Pharmed Co.,Unknown,False,COMPLETED,2022-08-28,2023-09-01,https://clinicaltrials.gov/study/NCT06021379,2022-08-28,0
NCT04419779,Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes,Fractyl Health Inc.,['NA'],False,RECRUITING,2025-06,2020-06-05,https://clinicaltrials.gov/study/NCT04419779,2025-06-01,0
NCT05202379,CC-42344 Safety Study in Healthy Participants,"Cocrystal Pharma, Inc.",['PHASE1'],False,COMPLETED,2023-03-29,2022-01-21,https://clinicaltrials.gov/study/NCT05202379,2023-03-29,0
NCT04505579,The Tether™ - Vertebral Body Tethering System Post Approval Study,ZimVie,Unknown,False,RECRUITING,2027-08-31,2020-08-10,https://clinicaltrials.gov/study/NCT04505579,2027-08-31,0
NCT03421379,A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus,Eli Lilly and Company,['PHASE3'],True,COMPLETED,2018-08-20,2018-02-05,https://clinicaltrials.gov/study/NCT03421379,2018-08-20,0
NCT05065879,Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes,China National Biotec Group Company Limited,['PHASE4'],False,COMPLETED,2022-01-05,2021-10-04,https://clinicaltrials.gov/study/NCT05065879,2022-01-05,1
NCT02654379,Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in Europe,Hoffmann-La Roche,Unknown,False,COMPLETED,2017-09-29,2016-01-13,https://clinicaltrials.gov/study/NCT02654379,2017-09-29,0
NCT04909879,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome,"Sorrento Therapeutics, Inc.",['PHASE2'],False,WITHDRAWN,2022-02,2021-06-02,https://clinicaltrials.gov/study/NCT04909879,2022-02-01,0
NCT03500679,A Study to Evaluate Safety and Immunogenicity of the ExPEC4V Clinical Trial Material After a Single Intramuscular Dose and a Second Dose 6 Months Later in Healthy Participants Aged 18 Years and Older,"Janssen Research & Development, LLC",['PHASE2'],True,COMPLETED,2018-11-05,2018-04-18,https://clinicaltrials.gov/study/NCT03500679,2018-11-05,0
NCT05938179,A Study of HS-10353 in Adult Participants With Major Depressive Disorder,"Jiangsu Hansoh Pharmaceutical Co., Ltd.",['PHASE2'],False,NOT_YET_RECRUITING,2024-11-01,2023-07-10,https://clinicaltrials.gov/study/NCT05938179,2024-11-01,0
NCT03894579,Autologous Natural Killer Cells in Subjects With Plaque Psoriasis,"NKGen Biotech, Inc.",['PHASE1'],False,COMPLETED,2019-12-03,2019-03-28,https://clinicaltrials.gov/study/NCT03894579,2019-12-03,0
NCT02027779,Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A,Green Cross Corporation,['PHASE3'],False,UNKNOWN,2015-12,2014-01-06,https://clinicaltrials.gov/study/NCT02027779,2015-12-01,0
NCT03569579,CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1),Chong Kun Dang Pharmaceutical,['PHASE1'],False,COMPLETED,2018-05-21,2018-06-26,https://clinicaltrials.gov/study/NCT03569579,2018-05-21,0
NCT05784779,Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD,"1Globe Biomedical Co., Ltd.","['PHASE1', 'PHASE2']",False,RECRUITING,2024-05-28,2023-03-27,https://clinicaltrials.gov/study/NCT05784779,2024-05-28,0
NCT03721679,Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1,"Oncovir, Inc.","['PHASE1', 'PHASE2']",False,TERMINATED,2021-01-26,2018-10-26,https://clinicaltrials.gov/study/NCT03721679,2021-01-26,0
NCT05394779,DEMETRA - ADVICE-002-2022,Advice Pharma Group srl,['NA'],False,COMPLETED,2023-12-18,2022-05-27,https://clinicaltrials.gov/study/NCT05394779,2023-12-18,0
NCT03724279,Crossing Atheroma or Thrombus With ByCross Device for Revascularization of Peripheral Arteries of Diameter ≥ 3mm,Taryag Medical Ltd.,['NA'],False,COMPLETED,2019-07-01,2018-10-30,https://clinicaltrials.gov/study/NCT03724279,2019-07-01,0
NCT04456179,Continuous Non-Invasive Blood Pressure System Data Collection in Comparison to Invasive Radial Arterial Pressure,Sensifree Ltd.,['NA'],False,COMPLETED,2020-02-06,2020-07-02,https://clinicaltrials.gov/study/NCT04456179,2020-02-06,0
NCT03044379,Dapivirine Gel Rectal Safety and PK Study,"International Partnership for Microbicides, Inc.",['PHASE1'],False,WITHDRAWN,2017-09,2017-02-07,https://clinicaltrials.gov/study/NCT03044379,2017-09-01,0
NCT05607979,Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds,Lavior Pharma Inc.,"['PHASE2', 'PHASE3']",False,COMPLETED,2024-05-01,2022-11-07,https://clinicaltrials.gov/study/NCT05607979,2024-05-01,0
NCT03251079,PRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and Algorithm,"Senseonics, Inc.",['NA'],True,COMPLETED,2018-02-01,2017-08-16,https://clinicaltrials.gov/study/NCT03251079,2018-02-01,0
NCT02207179,Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology,LumaMed,['EARLY_PHASE1'],False,UNKNOWN,2015-09,2014-08-04,https://clinicaltrials.gov/study/NCT02207179,2015-09-01,0
NCT03291379,Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies,Boston Scientific Corporation,['EARLY_PHASE1'],True,COMPLETED,2019-08-03,2017-09-25,https://clinicaltrials.gov/study/NCT03291379,2019-08-03,0
NCT02666079,The LightPath® Breast Cancer Study,Lightpoint Medical Limited,['NA'],False,UNKNOWN,2018-11,2016-01-28,https://clinicaltrials.gov/study/NCT02666079,2018-11-01,0
NCT02380079,Dose-Escalation Study of SCD-101 in Sickle Cell Disease,"Invenux, LLC",['PHASE1'],False,ACTIVE_NOT_RECRUITING,2023-11,2015-03-05,https://clinicaltrials.gov/study/NCT02380079,2023-11-01,0
NCT05899179,Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",['PHASE3'],False,RECRUITING,2025-06-30,2023-06-12,https://clinicaltrials.gov/study/NCT05899179,2025-06-30,0
NCT06204679,Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir,"Atea Pharmaceuticals, Inc.",['PHASE1'],False,COMPLETED,2024-08-25,2024-01-12,https://clinicaltrials.gov/study/NCT06204679,2024-08-25,0
NCT02040779,A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma,"Teva Branded Pharmaceutical Products R&D, Inc.",['PHASE3'],True,COMPLETED,2014-12-24,2014-01-20,https://clinicaltrials.gov/study/NCT02040779,2014-12-24,0
NCT05524779,BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement,BTL Industries Ltd.,['NA'],False,UNKNOWN,2023-04,2022-09-01,https://clinicaltrials.gov/study/NCT05524779,2023-04-01,0
NCT03698279,Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age,"Sanofi Pasteur, a Sanofi Company",['PHASE2'],True,COMPLETED,2019-10-16,2018-10-05,https://clinicaltrials.gov/study/NCT03698279,2019-10-16,0
NCT04103879,US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia,ExCellThera inc.,['PHASE2'],False,ACTIVE_NOT_RECRUITING,2026-02,2019-09-26,https://clinicaltrials.gov/study/NCT04103879,2026-02-01,0
NCT06283979,A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.,Biocomposites Ltd,['PHASE2'],False,NOT_YET_RECRUITING,2024-12-01,2024-02-28,https://clinicaltrials.gov/study/NCT06283979,2024-12-01,0
NCT04939779,Trial to Evaluate Bioequivalence of LCB01-0371 in Different Batches,"LigaChem Biosciences, Inc.",['PHASE1'],False,COMPLETED,2021-01-24,2021-06-25,https://clinicaltrials.gov/study/NCT04939779,2021-01-24,0
NCT03180879,Ibuprofen Bioavailability Study,Reckitt Benckiser Healthcare (UK) Limited,['PHASE1'],False,COMPLETED,2017-06-13,2017-06-08,https://clinicaltrials.gov/study/NCT03180879,2017-06-13,0
NCT05110079,Revascularization of Total or Sub-total Occluded Peripheral Arteries With ByCross® Device. Post Market Clinical Followup,Taryag Medical Ltd.,Unknown,False,UNKNOWN,2022-12-31,2021-11-05,https://clinicaltrials.gov/study/NCT05110079,2022-12-31,0
NCT02494479,Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis,Cellceutix Corporation,['PHASE2'],False,COMPLETED,2016-04,2015-07-10,https://clinicaltrials.gov/study/NCT02494479,2016-04-01,0
NCT04025879,"A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer",Bristol-Myers Squibb,['PHASE3'],True,ACTIVE_NOT_RECRUITING,2023-07-26,2019-07-19,https://clinicaltrials.gov/study/NCT04025879,2023-07-26,0
NCT04877379,VNRX-7145 Drug-Drug Interaction in Healthy Adult Volunteers,"Venatorx Pharmaceuticals, Inc.",['PHASE1'],False,COMPLETED,2021-11-10,2021-05-07,https://clinicaltrials.gov/study/NCT04877379,2021-11-10,0
NCT04944979,"Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)",Kedrion S.p.A.,['PHASE3'],False,RECRUITING,2026-04-30,2021-06-30,https://clinicaltrials.gov/study/NCT04944979,2026-04-30,0
NCT04469179,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19","SAb Biotherapeutics, Inc.",['PHASE1'],False,UNKNOWN,2021-02-25,2020-07-13,https://clinicaltrials.gov/study/NCT04469179,2021-02-25,0
NCT03260179,"Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810","Haihe Biopharma Co., Ltd.",['PHASE1'],False,UNKNOWN,2019-01-31,2017-08-24,https://clinicaltrials.gov/study/NCT03260179,2019-01-31,0
NCT01610479,A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors,"Taiho Pharmaceutical Co., Ltd.",['PHASE1'],False,COMPLETED,2017-02,2012-06-04,https://clinicaltrials.gov/study/NCT01610479,2017-02-01,0
NCT03192579,Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial,Kobe University,['PHASE4'],False,COMPLETED,2017-06-02,2017-06-20,https://clinicaltrials.gov/study/NCT03192579,2017-06-02,1
NCT04040179,A Volunteer Study to Collect Imaging Data for the Development of the ntelligentUltrasound Anatomy Guide,Medaphor Limited,Unknown,False,COMPLETED,2019-09-30,2019-07-31,https://clinicaltrials.gov/study/NCT04040179,2019-09-30,0
NCT03776279,A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma,"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.",['PHASE2'],False,UNKNOWN,2020-12-30,2018-12-14,https://clinicaltrials.gov/study/NCT03776279,2020-12-30,0
NCT05353179,Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",['EARLY_PHASE1'],False,UNKNOWN,2022-10,2022-04-29,https://clinicaltrials.gov/study/NCT05353179,2022-10-01,0
NCT01174979,Caroverin and Inner Ear Diseases,Phafag AG,['PHASE3'],False,SUSPENDED,2015-08,2010-08-04,https://clinicaltrials.gov/study/NCT01174979,2015-08-01,0
NCT06343779,Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema,Pharvaris Netherlands B.V.,['PHASE3'],False,RECRUITING,2026-03,2024-04-03,https://clinicaltrials.gov/study/NCT06343779,2026-03-01,0
NCT02897479,A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer,Hutchison Medipharma Limited,['PHASE2'],False,UNKNOWN,2021-12-30,2016-09-13,https://clinicaltrials.gov/study/NCT02897479,2021-12-30,0
NCT03148379,Single-use Efficiency Instruments With Patient Specific Technique (MyKnee®) Versus Traditional Metal Instruments With Conventional Surgical Technique,Medacta USA,['NA'],True,COMPLETED,2022-03-30,2017-05-11,https://clinicaltrials.gov/study/NCT03148379,2022-03-30,0
NCT05089279,Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers,Chong Kun Dang Pharmaceutical,['PHASE1'],False,COMPLETED,2022-01-18,2021-10-22,https://clinicaltrials.gov/study/NCT05089279,2022-01-18,0
NCT02537379,Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection,Gilead Sciences,Unknown,False,COMPLETED,2017-06-05,2015-09-01,https://clinicaltrials.gov/study/NCT02537379,2017-06-05,0
NCT05145179,"A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Potential Anti-tumor Effects of SSGJ-705 in Patients With Advanced or Metastatic HER2-expressing Solid Tumors","Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.",['PHASE1'],False,UNKNOWN,2023-12-01,2021-12-06,https://clinicaltrials.gov/study/NCT05145179,2023-12-01,0
NCT03928379,A Study of LY3305677 in Participants With Type 2 Diabetes,Eli Lilly and Company,['PHASE1'],False,COMPLETED,2021-07-08,2019-04-26,https://clinicaltrials.gov/study/NCT03928379,2021-07-08,0
NCT03105479,Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD),Actelion,"['PHASE2', 'PHASE3']",True,TERMINATED,2018-04-17,2017-04-10,https://clinicaltrials.gov/study/NCT03105479,2018-04-17,0
NCT04102579,"Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease",Neurocrine Biosciences,['PHASE3'],True,COMPLETED,2021-10-15,2019-09-25,https://clinicaltrials.gov/study/NCT04102579,2021-10-15,0
NCT04002479,Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer,Alpha Tau Medical LTD.,['NA'],False,RECRUITING,2025-10,2019-06-28,https://clinicaltrials.gov/study/NCT04002479,2025-10-01,0
NCT05529979,Epione® Post-Market Clinical Follow-up Study,Quantum Surgical,Unknown,False,ACTIVE_NOT_RECRUITING,2023-02-22,2022-09-07,https://clinicaltrials.gov/study/NCT05529979,2023-02-22,0
NCT05037279,Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC),Verity Pharmaceuticals Inc.,['PHASE3'],False,NOT_YET_RECRUITING,2025-12-30,2021-09-08,https://clinicaltrials.gov/study/NCT05037279,2025-12-30,0
NCT06211179,A Study to Assess the Relative Bioavailability of 5 mg Mavacamten Opened Capsule Administered Via Nasogastric Tube Compared to Intact Oral 5 mg Mavacamten in Healthy Participants,Bristol-Myers Squibb,['PHASE1'],False,COMPLETED,2024-06-13,2024-01-18,https://clinicaltrials.gov/study/NCT06211179,2024-06-13,0
NCT01810679,Perceval S Aortic Heart Valve Study- North America,"Sorin Group USA, Inc.",['NA'],False,TERMINATED,2016-02,2013-03-13,https://clinicaltrials.gov/study/NCT01810679,2016-02-01,0
NCT03438279,Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy,Bristol-Myers Squibb,Unknown,False,COMPLETED,2017-12-28,2018-02-19,https://clinicaltrials.gov/study/NCT03438279,2017-12-28,0
NCT06174779,A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus,Hanmi Pharmaceutical Company Limited,['PHASE3'],False,RECRUITING,2025-12-31,2023-12-18,https://clinicaltrials.gov/study/NCT06174779,2025-12-31,0
NCT03699579,Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC,Ipsen,Unknown,False,COMPLETED,2019-06-23,2018-10-09,https://clinicaltrials.gov/study/NCT03699579,2019-06-23,0
NCT06047379,"Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis","Neonc Technologies, Inc.","['PHASE1', 'PHASE2']",False,RECRUITING,2026-02-28,2023-09-21,https://clinicaltrials.gov/study/NCT06047379,2026-02-28,0
NCT05870579,"[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer",Novartis Pharmaceuticals,['PHASE1'],False,RECRUITING,2026-12-30,2023-05-23,https://clinicaltrials.gov/study/NCT05870579,2026-12-30,0
NCT05537779,Safety and Performance of Optivantage Multi-use When Injecting Contrast Media for Contrast Enhanced CT Examination,Guerbet,Unknown,False,UNKNOWN,2022-12,2022-09-13,https://clinicaltrials.gov/study/NCT05537779,2022-12-01,0
NCT04393779,Observational Registry on the HARPOON Device,Edwards Lifesciences,['NA'],True,TERMINATED,2022-11-17,2020-05-19,https://clinicaltrials.gov/study/NCT04393779,2022-11-17,0
NCT04653779,A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg,"Dong-A ST Co., Ltd.",['PHASE4'],False,UNKNOWN,2021-05,2020-12-04,https://clinicaltrials.gov/study/NCT04653779,2021-05-01,1
NCT03392779,"Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP1601, and the Effect of Food on ZSP1601 Pharmacokinetics","Guangdong Zhongsheng Pharmaceutical Co., Ltd.",['PHASE1'],False,COMPLETED,2018-12-21,2018-01-08,https://clinicaltrials.gov/study/NCT03392779,2018-12-21,0
NCT01696279,"A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis",Shire,['PHASE2'],True,COMPLETED,2018-11-16,2012-10-01,https://clinicaltrials.gov/study/NCT01696279,2018-11-16,0
NCT05653479,Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults,Upstream Bio Inc.,['PHASE1'],True,COMPLETED,2023-04-07,2022-12-16,https://clinicaltrials.gov/study/NCT05653479,2023-04-07,0
NCT04293679,"Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC",Sirnaomics,"['PHASE1', 'PHASE2']",False,COMPLETED,2020-10-21,2020-03-03,https://clinicaltrials.gov/study/NCT04293679,2020-10-21,0
NCT04475679,Clinical Evaluation of Adhese Universal DC in the Indirect Restorative Therapy,Ivoclar Vivadent AG,['NA'],False,ACTIVE_NOT_RECRUITING,2021-07-12,2020-07-17,https://clinicaltrials.gov/study/NCT04475679,2021-07-12,0
NCT05951179,Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer,Protara Therapeutics,['PHASE2'],False,RECRUITING,2030-05,2023-07-18,https://clinicaltrials.gov/study/NCT05951179,2030-05-01,0
NCT05056779,Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable,Galderma R&D,['PHASE3'],False,WITHDRAWN,2023-07,2021-09-27,https://clinicaltrials.gov/study/NCT05056779,2023-07-01,0
NCT04337879,A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","['PHASE1', 'PHASE2']",False,UNKNOWN,2020-12-31,2020-04-08,https://clinicaltrials.gov/study/NCT04337879,2020-12-31,0
NCT05437679,Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System,Angle plc,Unknown,False,TERMINATED,2023-08-22,2022-06-29,https://clinicaltrials.gov/study/NCT05437679,2023-08-22,0
NCT06623279,Open-laBel Dose-escalation Study for CRISPR/cas13- Rna TargetInG THerapy for the Treatment of Neovascular Age-related Macular Degeneration in Phase I Trial,"HuidaGene Therapeutics Co., Ltd.",['PHASE1'],False,NOT_YET_RECRUITING,2027-02-01,2024-10-02,https://clinicaltrials.gov/study/NCT06623279,2027-02-01,0
NCT06601179,"Evaluating the Safety and Efficacy of the ""HIFU"" High-intensity Focused Ultrasound Treatment of Benign Prostatic Hyperplasia;",EDAP TMS S.A.,['NA'],False,RECRUITING,2028-08-31,2024-09-19,https://clinicaltrials.gov/study/NCT06601179,2028-08-31,0
NCT06612879,A Study to Find Out How BIIB141 (Omaveloxolone) Moves From the Blood Into the Breastmilk of Healthy Women Who Are Breastfeeding or Pumping Milk,"Reata, a wholly owned subsidiary of Biogen",['PHASE1'],False,RECRUITING,2025-04-09,2024-09-25,https://clinicaltrials.gov/study/NCT06612879,2025-04-09,0
NCT02226679,An Open Label Rollover Trial for Patients Randomized to the Control Group of Study LSH-10-001,"LoneStar Heart, Inc.",['NA'],False,UNKNOWN,2016-04,2014-08-27,https://clinicaltrials.gov/study/NCT02226679,2016-04-01,0
NCT03071679,Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers,"Maruho Co., Ltd.",['PHASE1'],False,COMPLETED,2017-03-07,2017-03-07,https://clinicaltrials.gov/study/NCT03071679,2017-03-07,0
NCT03423979,Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter,Urotronic Inc.,['PHASE2'],True,COMPLETED,2019-06-04,2018-02-06,https://clinicaltrials.gov/study/NCT03423979,2019-06-04,0
NCT04149379,Hyperbaric Oxygen Therapy After Stroke - PILOT,Norwegian Underwater Intervention (NUI),['PHASE2'],False,WITHDRAWN,2021-08-31,2019-11-04,https://clinicaltrials.gov/study/NCT04149379,2021-08-31,0
NCT02073279,Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD),Hoffmann-La Roche,['PHASE3'],True,COMPLETED,2018-10-12,2014-02-27,https://clinicaltrials.gov/study/NCT02073279,2018-10-12,0
NCT04811079,The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer,"Johnson & Johnson Vision Care, Inc.",['NA'],False,COMPLETED,2022-05-16,2021-03-23,https://clinicaltrials.gov/study/NCT04811079,2022-05-16,0
NCT04484779,A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes,Eli Lilly and Company,['NA'],False,COMPLETED,2020-12-22,2020-07-24,https://clinicaltrials.gov/study/NCT04484779,2020-12-22,0
NCT03652779,A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers,Lee's Pharmaceutical Limited,['PHASE1'],False,COMPLETED,2019-10-28,2018-08-29,https://clinicaltrials.gov/study/NCT03652779,2019-10-28,0
NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma,Celldex Therapeutics,['PHASE3'],False,COMPLETED,2016-11,2011-11-29,https://clinicaltrials.gov/study/NCT01480479,2016-11-01,0
NCT02394379,Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL,Bausch & Lomb Incorporated,Unknown,False,COMPLETED,2019-08-05,2015-03-20,https://clinicaltrials.gov/study/NCT02394379,2019-08-05,0
NCT03495479,Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance,"Omnitura Therapeutics, Inc.",Unknown,False,WITHDRAWN,2028-01,2018-04-12,https://clinicaltrials.gov/study/NCT03495479,2028-01-01,0
NCT04473079,Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia,Lallemand Health Solutions,"['PHASE2', 'PHASE3']",False,COMPLETED,2022-06-17,2020-07-16,https://clinicaltrials.gov/study/NCT04473079,2022-06-17,0
NCT06096779,"A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis","Genentech, Inc.",['PHASE2'],False,RECRUITING,2026-05-02,2023-10-24,https://clinicaltrials.gov/study/NCT06096779,2026-05-02,0
NCT02919579,A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder,"Janssen Research & Development, LLC",['PHASE1'],False,COMPLETED,2018-06-29,2016-09-29,https://clinicaltrials.gov/study/NCT02919579,2018-06-29,0
NCT04926779,Study Utilizing BIOZEK COVID-19 Antigen Rapid Test,Mach-E B.V.,['NA'],True,COMPLETED,2022-11-04,2021-06-15,https://clinicaltrials.gov/study/NCT04926779,2022-11-04,0
NCT02360579,"Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma","Iovance Biotherapeutics, Inc.",['PHASE2'],False,ACTIVE_NOT_RECRUITING,2025-01-15,2015-02-10,https://clinicaltrials.gov/study/NCT02360579,2025-01-15,0
NCT06182579,Phase I Study of RiMO-401 With Radiation in Advanced Tumors,"Coordination Pharmaceuticals, Inc.",['PHASE1'],False,RECRUITING,2026-01,2023-12-27,https://clinicaltrials.gov/study/NCT06182579,2026-01-01,0
NCT04783779,Evaluation of STARgraft-2 for Hemodialysis Access,Healionics Corporation,['NA'],False,COMPLETED,2022-06-01,2021-03-05,https://clinicaltrials.gov/study/NCT04783779,2022-06-01,0
NCT04480879,Evaluation of AZD8154 Concentrations in Blood,AstraZeneca,['PHASE1'],False,TERMINATED,2020-09-02,2020-07-21,https://clinicaltrials.gov/study/NCT04480879,2020-09-02,0
NCT03109379,Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder,Taris Biomedical LLC,['PHASE1'],False,COMPLETED,2019-09-27,2017-04-12,https://clinicaltrials.gov/study/NCT03109379,2019-09-27,0
NCT05232279,Effect of Testofen on Erectile Function in an Adult Male Population,RDC Clinical Pty Ltd,['PHASE3'],False,RECRUITING,2025-06-30,2022-02-09,https://clinicaltrials.gov/study/NCT05232279,2025-06-30,0
NCT04457479,APERIO® HYBRID Thrombectomy Device for Flow Restoration in Vessels of Patients Experiencing Acute Ischemic Stroke,Acandis GmbH,Unknown,False,COMPLETED,2023-01-16,2020-07-07,https://clinicaltrials.gov/study/NCT04457479,2023-01-16,0
NCT04565379,Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients,Shaperon,['PHASE2'],False,COMPLETED,2021-04-13,2020-09-25,https://clinicaltrials.gov/study/NCT04565379,2021-04-13,0
NCT06360679,Clinical Feasibility Study of the BariTon™ System in Obese or Overweight Patients.,BariaTek Medical,['NA'],False,RECRUITING,2024-10-01,2024-04-11,https://clinicaltrials.gov/study/NCT06360679,2024-10-01,0
NCT03301779,Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial,Hemanext,['PHASE2'],True,COMPLETED,2019-03-06,2017-10-04,https://clinicaltrials.gov/study/NCT03301779,2019-03-06,0
NCT04483479,"Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety ""Roll-over"" Study (Rollover)",Enterin Inc.,['PHASE2'],True,TERMINATED,2022-02-17,2020-07-23,https://clinicaltrials.gov/study/NCT04483479,2022-02-17,0
NCT06178679,Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED),"ORA, Inc.",['PHASE3'],False,RECRUITING,2024-06-30,2023-12-21,https://clinicaltrials.gov/study/NCT06178679,2024-06-30,0
NCT05516979,A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment,SynAct Pharma Aps,['PHASE2'],False,COMPLETED,2023-07-20,2022-08-26,https://clinicaltrials.gov/study/NCT05516979,2023-07-20,0
NCT06092879,Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France,Novartis Pharmaceuticals,Unknown,False,RECRUITING,2026-12-15,2023-10-23,https://clinicaltrials.gov/study/NCT06092879,2026-12-15,0
NCT03937479,Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD,Verona Pharma plc,['PHASE2'],True,COMPLETED,2019-11-15,2019-05-03,https://clinicaltrials.gov/study/NCT03937479,2019-11-15,0
NCT06034379,Electronic Spectacles Versus Low Dose Atropine in Young Myopes,Kubota Vision Inc.,['NA'],False,NOT_YET_RECRUITING,2025-03,2023-09-13,https://clinicaltrials.gov/study/NCT06034379,2025-03-01,0
NCT05431179,A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma,"Oncternal Therapeutics, Inc",['PHASE3'],False,WITHDRAWN,2026-11,2022-06-24,https://clinicaltrials.gov/study/NCT05431179,2026-11-01,0
NCT05737979,Modified Rekovelle and Menopur Combination Protocol to Avoid Monitoring Before Day 10 of Stimulation,Clinique Ovo,Unknown,False,COMPLETED,2023-11-30,2023-02-21,https://clinicaltrials.gov/study/NCT05737979,2023-11-30,0
NCT06222879,Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer,"Shandong Suncadia Medicine Co., Ltd.","['PHASE1', 'PHASE2']",False,NOT_YET_RECRUITING,2026-10-31,2024-01-25,https://clinicaltrials.gov/study/NCT06222879,2026-10-31,0
NCT02420379,Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",['PHASE2'],True,COMPLETED,2018-12-17,2015-04-17,https://clinicaltrials.gov/study/NCT02420379,2018-12-17,0
NCT05897879,Impact of Bacterial Expression and Immune Response in the Severity of Pertussis,Institut Pasteur,['NA'],False,RECRUITING,2025-11-16,2023-06-09,https://clinicaltrials.gov/study/NCT05897879,2025-11-16,0
NCT04848779,A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD),Sanofi,Unknown,False,RECRUITING,2026-03-30,2021-04-19,https://clinicaltrials.gov/study/NCT04848779,2026-03-30,0
NCT02161679,Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer,Gilead Sciences,['PHASE2'],False,WITHDRAWN,2016-08,2014-06-12,https://clinicaltrials.gov/study/NCT02161679,2016-08-01,0
NCT05929079,A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight,Eli Lilly and Company,['PHASE3'],False,ACTIVE_NOT_RECRUITING,2026-05-03,2023-07-03,https://clinicaltrials.gov/study/NCT05929079,2026-05-03,0
NCT06264479,Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2,"Ourotech, Inc.",Unknown,False,NOT_YET_RECRUITING,2028-09-30,2024-02-20,https://clinicaltrials.gov/study/NCT06264479,2028-09-30,0
NCT02628379,Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary,Foundation Medicine,Unknown,False,COMPLETED,2017-03,2015-12-11,https://clinicaltrials.gov/study/NCT02628379,2017-03-01,0
NCT01726179,Efficacy of Proximal Caries Infiltration,DMG Dental Material Gesellschaft mbH,['NA'],False,COMPLETED,2017-12,2012-11-14,https://clinicaltrials.gov/study/NCT01726179,2017-12-01,0
NCT04886479,Comparing Silicone Hydrogel Contact Lens Wearers to Hydrogel Contact Lens Wearers and Non-lens Wearers,"Coopervision, Inc.",['NA'],True,COMPLETED,2022-10-07,2021-05-14,https://clinicaltrials.gov/study/NCT04886479,2022-10-07,0
NCT06415279,A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients,Sun Pharmaceutical Industries Limited,['PHASE4'],False,ACTIVE_NOT_RECRUITING,2025-02,2024-05-16,https://clinicaltrials.gov/study/NCT06415279,2025-02-01,1
NCT05835479,Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults,Mundipharma Research Limited,['PHASE2'],False,RECRUITING,2024-10,2023-04-28,https://clinicaltrials.gov/study/NCT05835479,2024-10-01,0
NCT02460679,Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS),PTC Therapeutics,['PHASE2'],True,COMPLETED,2018-02-23,2015-06-02,https://clinicaltrials.gov/study/NCT02460679,2018-02-23,0
NCT03574779,A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer,"Tesaro, Inc.",['PHASE2'],False,ACTIVE_NOT_RECRUITING,2025-08-20,2018-07-02,https://clinicaltrials.gov/study/NCT03574779,2025-08-20,0
NCT03872479,Single Ascending Dose Study in Participants With LCA10,"Editas Medicine, Inc.","['PHASE1', 'PHASE2']",False,ACTIVE_NOT_RECRUITING,2025-05-23,2019-03-13,https://clinicaltrials.gov/study/NCT03872479,2025-05-23,0
NCT03049579,Immune System Stimulation by Probiotic Food Supplementation,"Hangzhou Wei Chuan Foods Co., Ltd.",['NA'],False,COMPLETED,2016-04-10,2017-02-10,https://clinicaltrials.gov/study/NCT03049579,2016-04-10,0
NCT06430879,Performance Output With Haptics - Evaluating Athlete Response and Unrealized Potential,SuperPatch Limited LLC,['NA'],False,NOT_YET_RECRUITING,2024-09-01,2024-05-28,https://clinicaltrials.gov/study/NCT06430879,2024-09-01,0
NCT02221479,Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma,"Genzyme, a Sanofi Company",['PHASE2'],False,COMPLETED,2015-07,2014-08-20,https://clinicaltrials.gov/study/NCT02221479,2015-07-01,0
NCT03817879,Double-lumen Tubes (DLT) - Health Economic Study,Ambu A/S,['NA'],True,COMPLETED,2019-01-31,2019-01-28,https://clinicaltrials.gov/study/NCT03817879,2019-01-31,0
NCT03006679,A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia,"Melinta Therapeutics, Inc.",['PHASE3'],False,WITHDRAWN,2020-06,2016-12-30,https://clinicaltrials.gov/study/NCT03006679,2020-06-01,0
NCT05336279,Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition,"Jiangsu HengRui Medicine Co., Ltd.",['PHASE1'],False,COMPLETED,2022-05-27,2022-04-20,https://clinicaltrials.gov/study/NCT05336279,2022-05-27,0
NCT02888379,Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis,Topivert Pharma Ltd,['PHASE2'],False,COMPLETED,2017-06-28,2016-09-05,https://clinicaltrials.gov/study/NCT02888379,2017-06-28,0
NCT03561779,Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee,"Yooyoung Pharmaceutical Co., Ltd.",['PHASE3'],False,COMPLETED,2019-06-14,2018-06-19,https://clinicaltrials.gov/study/NCT03561779,2019-06-14,0
NCT03410979,"A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2737 in Healthy Subjects",Galapagos NV,['PHASE1'],False,COMPLETED,2017-08-15,2018-01-25,https://clinicaltrials.gov/study/NCT03410979,2017-08-15,0
NCT00862979,"A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients",Novartis Pharmaceuticals,['PHASE4'],True,COMPLETED,2017-03-06,2009-03-17,https://clinicaltrials.gov/study/NCT00862979,2017-03-06,1
NCT02918279,Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity,Novo Nordisk A/S,['PHASE3'],True,COMPLETED,2019-02-14,2016-09-28,https://clinicaltrials.gov/study/NCT02918279,2019-02-14,0
NCT03706079,"Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma",AstraZeneca,['PHASE3'],True,COMPLETED,2021-10-26,2018-10-15,https://clinicaltrials.gov/study/NCT03706079,2021-10-26,0
NCT05043779,Evaluation of Preoperative Nasoendoscopy to Predict Difficult Intubation,Hamad Medical Corporation,['NA'],False,UNKNOWN,2022-03-01,2021-09-14,https://clinicaltrials.gov/study/NCT05043779,2022-03-01,0
NCT02283879,Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela,"Shenzhen Hornetcorn Bio-technology Company, LTD",['PHASE1'],False,UNKNOWN,2016-12,2014-11-05,https://clinicaltrials.gov/study/NCT02283879,2016-12-01,0
NCT06095479,Ultrasound Liver Fat Quantification on Pediatric Patients,"Philips (China) Investment CO., LTD",['NA'],False,RECRUITING,2024-06-30,2023-10-23,https://clinicaltrials.gov/study/NCT06095479,2024-06-30,0
NCT05650879,ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer,Enliven Therapeutics,['PHASE1'],False,RECRUITING,2026-07,2022-12-14,https://clinicaltrials.gov/study/NCT05650879,2026-07-01,0
NCT02933879,"Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study",Taro Pharmaceuticals USA,['PHASE2'],True,COMPLETED,2018-03-06,2016-10-14,https://clinicaltrials.gov/study/NCT02933879,2018-03-06,0
NCT03446079,Relationship of Skin Related SNP to Topical Skin Care Product,HelicalCodeMD,['NA'],False,COMPLETED,2019-01-31,2018-02-26,https://clinicaltrials.gov/study/NCT03446079,2019-01-31,0
NCT04107779,Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS,"Juul Labs, Inc.",['NA'],False,COMPLETED,2020-02-17,2019-09-27,https://clinicaltrials.gov/study/NCT04107779,2020-02-17,0
NCT03197779,"A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects",Bristol-Myers Squibb,['PHASE1'],False,COMPLETED,2016-02-02,2017-06-23,https://clinicaltrials.gov/study/NCT03197779,2016-02-02,0
NCT06369779,Clinical Evaluation of a New Flowable and a New Sculptable Universal Bulk-fill Composite for Direct Restorative Treatment,Ivoclar Vivadent AG,['NA'],False,RECRUITING,2024-12,2024-04-17,https://clinicaltrials.gov/study/NCT06369779,2024-12-01,0
NCT04968379,"Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia","American Regent, Inc.",['PHASE2'],False,WITHDRAWN,2024-10-08,2021-07-20,https://clinicaltrials.gov/study/NCT04968379,2024-10-08,0
NCT01285479,The Gilenya Pregnancy Registry,Novartis Pharmaceuticals,Unknown,False,RECRUITING,2031-01-02,2011-01-28,https://clinicaltrials.gov/study/NCT01285479,2031-01-02,0
NCT04057079,Comparing Anugel With Gelatine Sponges for Pain Management After Hemoroidectomy,Deep Life Medical Ltd,['PHASE2'],False,COMPLETED,2018-07-09,2019-08-15,https://clinicaltrials.gov/study/NCT04057079,2018-07-09,0
NCT02204579,A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations,Shire,['PHASE2'],True,COMPLETED,2015-05-04,2014-07-30,https://clinicaltrials.gov/study/NCT02204579,2015-05-04,0
NCT03734679,Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (AVess FIH),"SurModics, Inc.",['NA'],True,ACTIVE_NOT_RECRUITING,2020-02-19,2018-11-08,https://clinicaltrials.gov/study/NCT03734679,2020-02-19,0
NCT04852679,Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs,Ipsen,['PHASE3'],True,COMPLETED,2022-06-10,2021-04-21,https://clinicaltrials.gov/study/NCT04852679,2022-06-10,0
NCT06238479,"A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors",Eli Lilly and Company,['PHASE1'],False,RECRUITING,2026-08-26,2024-02-02,https://clinicaltrials.gov/study/NCT06238479,2026-08-26,0
NCT04233879,"Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)",Merck Sharp & Dohme LLC,['PHASE3'],True,ACTIVE_NOT_RECRUITING,2022-11-17,2020-01-18,https://clinicaltrials.gov/study/NCT04233879,2022-11-17,0
NCT04179279,Comparative Analysis of a Non-contact Respiratory and Heart Rate Monitor Vs. a Conventional Clinically Validated Reference Monitor,ContinUse Biometrics Ltd.,Unknown,False,COMPLETED,2020-01-27,2019-11-27,https://clinicaltrials.gov/study/NCT04179279,2020-01-27,0
NCT02715479,A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176,ViiV Healthcare,['PHASE1'],False,COMPLETED,2016-05,2016-03-22,https://clinicaltrials.gov/study/NCT02715479,2016-05-01,0
NCT01792479,A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer,BIND Therapeutics,['PHASE2'],False,COMPLETED,2016-04,2013-02-15,https://clinicaltrials.gov/study/NCT01792479,2016-04-01,0
NCT06335979,An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).,Novartis Pharmaceuticals,['PHASE1'],False,RECRUITING,2027-07-08,2024-03-28,https://clinicaltrials.gov/study/NCT06335979,2027-07-08,0
NCT03106779,"Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs",Novartis Pharmaceuticals,['PHASE3'],True,ACTIVE_NOT_RECRUITING,2020-05-25,2017-04-10,https://clinicaltrials.gov/study/NCT03106779,2020-05-25,0
NCT06169579,"An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers","Shenzhen NewDEL Biotech, Co., Ltd",['PHASE1'],False,ENROLLING_BY_INVITATION,2025-12,2023-12-13,https://clinicaltrials.gov/study/NCT06169579,2025-12-01,0
NCT06503679,"A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy Participants","DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company",['PHASE1'],False,RECRUITING,2024-12-31,2024-07-16,https://clinicaltrials.gov/study/NCT06503679,2024-12-31,0
NCT03880279,Autologous TAC T Cells Targeting CD19 in R/R Large B-Cell Lymphoma,"Triumvira Immunologics, Inc.","['PHASE1', 'PHASE2']",False,WITHDRAWN,2022-04,2019-03-19,https://clinicaltrials.gov/study/NCT03880279,2022-04-01,0
NCT04324879,A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL),"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",['PHASE2'],False,UNKNOWN,2022-12,2020-03-27,https://clinicaltrials.gov/study/NCT04324879,2022-12-01,0
NCT03303079,Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine,"Otsuka Pharmaceutical Co., Ltd.","['PHASE2', 'PHASE3']",True,COMPLETED,2019-11-30,2017-10-05,https://clinicaltrials.gov/study/NCT03303079,2019-11-30,0
NCT03590379,Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD),Chiesi Farmaceutici S.p.A.,['PHASE2'],False,COMPLETED,2018-10-16,2018-07-18,https://clinicaltrials.gov/study/NCT03590379,2018-10-16,0
NCT05970679,Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A,"Daewon Pharmaceutical Co., Ltd.",['PHASE3'],False,COMPLETED,2023-04-13,2023-08-01,https://clinicaltrials.gov/study/NCT05970679,2023-04-13,0
NCT05423379,XIENCE Skypoint Large Vessel Post Approval Study,Abbott Medical Devices,Unknown,False,ACTIVE_NOT_RECRUITING,2025-08-30,2022-06-21,https://clinicaltrials.gov/study/NCT05423379,2025-08-30,0
NCT03661879,Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity,Novo Nordisk A/S,['PHASE1'],False,COMPLETED,2019-09-05,2018-09-07,https://clinicaltrials.gov/study/NCT03661879,2019-09-05,0
NCT05113979,Early Feasibility Study to Evaluate the AccuraSee in Correcting Residual Refractive Errors After Cataract Surgery,OnPoint Vision Inc,Unknown,True,COMPLETED,2022-09-09,2021-11-09,https://clinicaltrials.gov/study/NCT05113979,2022-09-09,0
NCT05860179,Examination of Trends in Multiple Myeloma Trial Patient Experiences,Power Life Sciences Inc.,Unknown,False,NOT_YET_RECRUITING,2025-05,2023-05-16,https://clinicaltrials.gov/study/NCT05860179,2025-05-01,0
NCT02074579,A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome,Tsumura USA,['PHASE2'],False,COMPLETED,2016-04,2014-02-28,https://clinicaltrials.gov/study/NCT02074579,2016-04-01,0
NCT04616079,Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers,Regeneron Pharmaceuticals,['PHASE1'],False,TERMINATED,2021-06-01,2020-11-04,https://clinicaltrials.gov/study/NCT04616079,2021-06-01,0
NCT06113679,Pilot Randomized Study of RD-X19 Tx Device in Subjects With PCC (Long Covid) in the Outpatient Setting,EmitBio Inc.,['NA'],False,TERMINATED,2024-05-24,2023-11-02,https://clinicaltrials.gov/study/NCT06113679,2024-05-24,0
NCT00990379,Using Heavy Water to Study Cell Dynamics in Parkinson's Disease,Salena Killion,Unknown,False,UNKNOWN,2016-02,2009-10-06,https://clinicaltrials.gov/study/NCT00990379,2016-02-01,0
NCT05905679,Effects of a Probiotic on Aspects of Mental Wellness,Fonterra Research Centre,['NA'],False,COMPLETED,2023-09-12,2023-06-15,https://clinicaltrials.gov/study/NCT05905679,2023-09-12,0
NCT05041179,Bioavailability of PRUVIN® and Its Effects in Healthy Subjects (INDIGO),Société des Produits Nestlé (SPN),['NA'],False,COMPLETED,2020-04-01,2021-09-10,https://clinicaltrials.gov/study/NCT05041179,2020-04-01,0
NCT02554279,MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population,Ferring Pharmaceuticals,['PHASE4'],True,COMPLETED,2017-01-26,2015-09-18,https://clinicaltrials.gov/study/NCT02554279,2017-01-26,1
NCT05568979,Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23,"Sanofi Pasteur, a Sanofi Company",Unknown,False,COMPLETED,2022-11-29,2022-10-06,https://clinicaltrials.gov/study/NCT05568979,2022-11-29,0
NCT01631279,A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors,"Proacta, Incorporated","['PHASE1', 'PHASE2']",False,TERMINATED,2015-03,2012-06-29,https://clinicaltrials.gov/study/NCT01631279,2015-03-01,0
NCT04579679,Open-Label Surufatinib in European Patients With NET,Hutchmed,['PHASE2'],False,ACTIVE_NOT_RECRUITING,2024-09-15,2020-10-08,https://clinicaltrials.gov/study/NCT04579679,2024-09-15,0
NCT05194579,Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled Syringe,Pfizer,['PHASE1'],True,COMPLETED,2022-08-10,2022-01-18,https://clinicaltrials.gov/study/NCT05194579,2022-08-10,0
NCT03248479,Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies,Gilead Sciences,['PHASE1'],False,TERMINATED,2023-09-05,2017-08-14,https://clinicaltrials.gov/study/NCT03248479,2023-09-05,0
NCT02525679,"Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers",Boehringer Ingelheim,['PHASE1'],True,COMPLETED,2016-05-27,2015-08-17,https://clinicaltrials.gov/study/NCT02525679,2016-05-27,0
NCT06261879,Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood,WomenX Biotech Limited,['NA'],False,RECRUITING,2025-06,2024-02-15,https://clinicaltrials.gov/study/NCT06261879,2025-06-01,0
NCT03409679,Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa,Polyphor Ltd.,['PHASE3'],False,TERMINATED,2019-07-17,2018-01-24,https://clinicaltrials.gov/study/NCT03409679,2019-07-17,0
NCT06402279,Hemoperfusion Efferon СT for the Extremely Severe Form of COVID-19,Efferon JSC,Unknown,False,COMPLETED,2022-02-28,2024-05-07,https://clinicaltrials.gov/study/NCT06402279,2022-02-28,0
NCT02478879,A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen,Zosano Pharma Corporation,['PHASE1'],False,COMPLETED,2015-11,2015-06-23,https://clinicaltrials.gov/study/NCT02478879,2015-11-01,0
NCT05713279,Study of Flonoltinib Maleate Tablets in the Treatment of Severe Novel Coronavirus (COVID-19) Infection,"Chengdu Zenitar Biomedical Technology Co., Ltd",['NA'],False,ACTIVE_NOT_RECRUITING,2023-11-01,2023-02-06,https://clinicaltrials.gov/study/NCT05713279,2023-11-01,0
NCT02758379,Shockwave Coronary Lithoplasty Study,"Shockwave Medical, Inc.",['NA'],False,COMPLETED,2016-01,2016-05-02,https://clinicaltrials.gov/study/NCT02758379,2016-01-01,0
NCT03673579,"Clinical Evaluation of the ""NICU Clinical Decision Support Dashboard"" - MHSB",Philips Healthcare,['NA'],False,WITHDRAWN,2020-04-01,2018-09-17,https://clinicaltrials.gov/study/NCT03673579,2020-04-01,0
NCT01960179,Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes,Sanofi,['PHASE3'],False,COMPLETED,2015-03,2013-10-10,https://clinicaltrials.gov/study/NCT01960179,2015-03-01,0
NCT03914079,"Evaluation of the CAD-det System, a Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease",AusculSciences Canada Inc.,Unknown,False,SUSPENDED,2022-12,2019-04-16,https://clinicaltrials.gov/study/NCT03914079,2022-12-01,0
NCT06308679,A Bioequivalence Study of Two Formulations of 10-mg Empagliflozin Tablets in Healthy Thai Volunteers Under Fasting Conditions,Pharma Nueva,['PHASE1'],False,NOT_YET_RECRUITING,2024-05-31,2024-03-13,https://clinicaltrials.gov/study/NCT06308679,2024-05-31,0
NCT02456779,Validation of a Non-invasive In-vitro Diagnostic Test (Peptest) Against Other Diagnostic Methods for GERD,MAAB (Shanghai) Medical Device Limited,Unknown,False,COMPLETED,2017-01,2015-05-29,https://clinicaltrials.gov/study/NCT02456779,2017-01-01,0
NCT01715779,Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies,Novartis,Unknown,False,COMPLETED,2015-06,2012-10-29,https://clinicaltrials.gov/study/NCT01715779,2015-06-01,0
NCT02516579,European Sickle Cell Disease Cohort - Hydroxyurea,Theravia,Unknown,True,COMPLETED,2019-03-20,2015-08-06,https://clinicaltrials.gov/study/NCT02516579,2019-03-20,0
NCT05184179,Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab,Daewoong Pharmaceutical Co. LTD.,Unknown,False,COMPLETED,2022-08-16,2022-01-11,https://clinicaltrials.gov/study/NCT05184179,2022-08-16,0
NCT03213379,Assessment of Actigraphy Procedures on the Initiation of an Apomorphine Treatment Delivered Through a Pump to Patients With Parkinson's Disease,Orkyn',['NA'],False,UNKNOWN,2018-09-15,2017-07-11,https://clinicaltrials.gov/study/NCT03213379,2018-09-15,0
NCT03551379,A Double Balloon Endoscopic Platform for ESD,"Lumendi, LLC",Unknown,False,COMPLETED,2018-03-09,2018-06-11,https://clinicaltrials.gov/study/NCT03551379,2018-03-09,0
NCT04501679,A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN),Galderma R&D,['PHASE3'],True,COMPLETED,2022-03-30,2020-08-06,https://clinicaltrials.gov/study/NCT04501679,2022-03-30,0
NCT05522179,Nutritional Supplements and Foot Surgery,NutraHeal,['NA'],False,COMPLETED,2023-03-17,2022-08-30,https://clinicaltrials.gov/study/NCT05522179,2023-03-17,0
NCT04016779,Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD,"Supernus Pharmaceuticals, Inc.",['PHASE3'],True,COMPLETED,2020-10-10,2019-07-11,https://clinicaltrials.gov/study/NCT04016779,2020-10-10,0
NCT03604679,SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors,SymBio Pharmaceuticals,['PHASE1'],False,COMPLETED,2020-09-11,2018-07-27,https://clinicaltrials.gov/study/NCT03604679,2020-09-11,0
NCT02679079,Safety and Efficacy Study of NBI-98854 in Children and Adolescents With Tourette Syndrome,Neurocrine Biosciences,['PHASE2'],True,COMPLETED,2017-04-14,2016-02-10,https://clinicaltrials.gov/study/NCT02679079,2017-04-14,0
NCT03466879,A User Study of SYNUS Pain Relief Made by Tivic Health Systems,Tivic Health Systems,Unknown,False,COMPLETED,2018-07-21,2018-03-15,https://clinicaltrials.gov/study/NCT03466879,2018-07-21,0
NCT05050279,A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People,LEO Pharma,['EARLY_PHASE1'],False,COMPLETED,2022-01-04,2021-09-20,https://clinicaltrials.gov/study/NCT05050279,2022-01-04,0
NCT03347279,Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma,AstraZeneca,['PHASE3'],True,COMPLETED,2020-09-08,2017-11-20,https://clinicaltrials.gov/study/NCT03347279,2020-09-08,0
NCT01585779,Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial,Medtronic Cardiovascular,Unknown,True,COMPLETED,2016-06,2012-04-26,https://clinicaltrials.gov/study/NCT01585779,2016-06-01,0
NCT03804879,"Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy",Novartis Pharmaceuticals,['PHASE2'],True,COMPLETED,2021-05-03,2019-01-15,https://clinicaltrials.gov/study/NCT03804879,2021-05-03,0
NCT05670379,"Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant","Vivani Medical, Inc",['PHASE1'],False,NOT_YET_RECRUITING,2025-08,2023-01-04,https://clinicaltrials.gov/study/NCT05670379,2025-08-01,0
NCT03945279,"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis",Biogen,['PHASE1'],False,COMPLETED,2021-06-21,2019-05-10,https://clinicaltrials.gov/study/NCT03945279,2021-06-21,0
NCT04935879,A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises,Pfizer,['PHASE3'],False,COMPLETED,2024-06-06,2021-06-23,https://clinicaltrials.gov/study/NCT04935879,2024-06-06,0
NCT02156479,Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients,Lophius Biosciences GmbH,Unknown,False,COMPLETED,2018-04,2014-06-05,https://clinicaltrials.gov/study/NCT02156479,2018-04-01,0
NCT03628079,A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.,Repos Pharma,"['PHASE1', 'PHASE2']",False,TERMINATED,2019-01-16,2018-08-14,https://clinicaltrials.gov/study/NCT03628079,2019-01-16,0
NCT01388179,Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children.,Brainsway,['PHASE2'],False,TERMINATED,2016-12-31,2011-07-06,https://clinicaltrials.gov/study/NCT01388179,2016-12-31,0
NCT04209179,"A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism",Chugai Pharmaceutical,['PHASE1'],False,TERMINATED,2020-12-28,2019-12-24,https://clinicaltrials.gov/study/NCT04209179,2020-12-28,0
NCT06610279,A Study of TAK-951 in Healthy Adults,Takeda,['PHASE1'],True,TERMINATED,2023-09-21,2024-09-24,https://clinicaltrials.gov/study/NCT06610279,2023-09-21,0
NCT03560479,A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer,Hamlet Pharma AB,"['PHASE1', 'PHASE2']",False,UNKNOWN,2021-12,2018-06-18,https://clinicaltrials.gov/study/NCT03560479,2021-12-01,0
NCT05411679,EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer,Ellipses Pharma,['PHASE2'],False,WITHDRAWN,2024-08,2022-06-09,https://clinicaltrials.gov/study/NCT05411679,2024-08-01,0
NCT02985879,"A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP)",AbbVie,['PHASE2'],True,TERMINATED,2019-11-20,2016-12-07,https://clinicaltrials.gov/study/NCT02985879,2019-11-20,0
NCT01672879,"Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH",Gilead Sciences,['PHASE2'],True,TERMINATED,2016-09-26,2012-08-27,https://clinicaltrials.gov/study/NCT01672879,2016-09-26,0
NCT04803279,"Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear",Oticon Medical,Unknown,False,UNKNOWN,2021-05-16,2021-03-17,https://clinicaltrials.gov/study/NCT04803279,2021-05-16,0
NCT04978779,A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome,"Vincerx Pharma, Inc.",['PHASE1'],False,TERMINATED,2023-05-26,2021-07-27,https://clinicaltrials.gov/study/NCT04978779,2023-05-26,0
NCT02940379,A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol,Sanofi,['PHASE1'],False,COMPLETED,2016-12,2016-10-20,https://clinicaltrials.gov/study/NCT02940379,2016-12-01,0
NCT03774979,SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors,"Jiangsu HengRui Medicine Co., Ltd.",['PHASE1'],False,UNKNOWN,2023-03,2018-12-13,https://clinicaltrials.gov/study/NCT03774979,2023-03-01,0
NCT03199079,Cervix Monitor for Elasticity and Length Measurements,"Advanced Tactile Imaging, Inc.",Unknown,True,COMPLETED,2022-04-27,2017-06-26,https://clinicaltrials.gov/study/NCT03199079,2022-04-27,0
NCT01498484,Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies,Atara Biotherapeutics,['PHASE2'],True,COMPLETED,2019-07,2011-12-23,https://clinicaltrials.gov/study/NCT01498484,2019-07-01,0
NCT06697184,A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.,BeiGene,"['PHASE1', 'PHASE2']",False,NOT_YET_RECRUITING,2027-06,2024-11-20,https://clinicaltrials.gov/study/NCT06697184,2027-06-01,0
NCT02899884,Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain,Takeda,Unknown,True,COMPLETED,2018-04-04,2016-09-14,https://clinicaltrials.gov/study/NCT02899884,2018-04-04,0
NCT03686384,SVT-15652 Otic Solution for the Treatment of Otomycosis,Salvat,['PHASE3'],True,COMPLETED,2021-10-25,2018-09-26,https://clinicaltrials.gov/study/NCT03686384,2021-10-25,0
NCT06435884,Long-Term Follow-up of Adult With Atorpphic Scars Treated With TRTP-101,CellinCells,Unknown,False,RECRUITING,2029-09,2024-05-30,https://clinicaltrials.gov/study/NCT06435884,2029-09-01,0
NCT02278484,Sinus Balloon Dilation in Pediatric Patients,"Entellus Medical, Inc.",['NA'],True,COMPLETED,2015-09,2014-10-30,https://clinicaltrials.gov/study/NCT02278484,2015-09-01,0
NCT06691984,Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer,Amgen,['PHASE3'],False,NOT_YET_RECRUITING,2028-08-31,2024-11-18,https://clinicaltrials.gov/study/NCT06691984,2028-08-31,0
NCT06067984,An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia,"Click Therapeutics, Inc.",['PHASE3'],False,RECRUITING,2024-09-24,2023-10-05,https://clinicaltrials.gov/study/NCT06067984,2024-09-24,0
NCT05485584,rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19,Sichuan Huiyang Life Science and Technology Corporation,['PHASE2'],False,ACTIVE_NOT_RECRUITING,2023-04-05,2022-08-03,https://clinicaltrials.gov/study/NCT05485584,2023-04-05,0
NCT03249584,OsteoCool Tumor Ablation Post-Market Study,MedtronicNeuro,['NA'],True,COMPLETED,2019-04-30,2017-08-15,https://clinicaltrials.gov/study/NCT03249584,2019-04-30,0
NCT02968784,Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer,InSightec,['NA'],False,TERMINATED,2023-02-02,2016-11-21,https://clinicaltrials.gov/study/NCT02968784,2023-02-02,0
NCT01991184,A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.,"Genentech, Inc.",['PHASE1'],False,COMPLETED,2022-03-08,2013-11-25,https://clinicaltrials.gov/study/NCT01991184,2022-03-08,0
NCT02470884,FAST Feasibility Study,Boston Scientific Corporation,['NA'],False,COMPLETED,2017-01-31,2015-06-12,https://clinicaltrials.gov/study/NCT02470884,2017-01-31,0
NCT02615184,A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old,Takeda,['PHASE2'],False,RECRUITING,2027-10-31,2015-11-26,https://clinicaltrials.gov/study/NCT02615184,2027-10-31,0
NCT06136884,"A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors",A2A Pharmaceuticals Inc.,['PHASE1'],False,RECRUITING,2025-10-28,2023-11-18,https://clinicaltrials.gov/study/NCT06136884,2025-10-28,0
NCT04951284,Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension,Novoic Limited,Unknown,False,TERMINATED,2022-11-21,2021-07-06,https://clinicaltrials.gov/study/NCT04951284,2022-11-21,0
NCT05302284,A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma,"RemeGen Co., Ltd.",['PHASE3'],False,RECRUITING,2026-12-31,2022-03-31,https://clinicaltrials.gov/study/NCT05302284,2026-12-31,0
NCT05300984,Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product,Amazentis SA,['NA'],False,COMPLETED,2022-05-10,2022-03-29,https://clinicaltrials.gov/study/NCT05300984,2022-05-10,0
NCT02928484,Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function,Biopolis S.L.,"['PHASE1', 'PHASE2']",False,UNKNOWN,2017-06,2016-10-10,https://clinicaltrials.gov/study/NCT02928484,2017-06-01,0
NCT05783284,HS2 US Liver Reader Study,HoloCare AS,Unknown,False,COMPLETED,2023-03-04,2023-03-24,https://clinicaltrials.gov/study/NCT05783284,2023-03-04,0
NCT06524284,Feasibility of Self-treatment of Painful Diabetic Neuropathy Using Electrical Vasomotor Nerve Stimulation,Neurecon BV,['NA'],False,RECRUITING,2024-11,2024-07-29,https://clinicaltrials.gov/study/NCT06524284,2024-11-01,0
NCT02781584,"Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)",Gilead Sciences,['PHASE2'],True,COMPLETED,2020-12-17,2016-05-24,https://clinicaltrials.gov/study/NCT02781584,2020-12-17,0
NCT02483884,PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer,Life Molecular Imaging SA,"['PHASE1', 'PHASE2']",False,TERMINATED,2016-12,2015-06-29,https://clinicaltrials.gov/study/NCT02483884,2016-12-01,0
NCT04728984,A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet,"Shenyang Sunshine Pharmaceutical Co., LTD.",['PHASE3'],False,UNKNOWN,2021-06-30,2021-01-28,https://clinicaltrials.gov/study/NCT04728984,2021-06-30,0
NCT04697784,Post-Approval Study of the TREO Abdominal Stent-Graft System,Bolton Medical,['NA'],False,RECRUITING,2027-07-31,2021-01-06,https://clinicaltrials.gov/study/NCT04697784,2027-07-31,0
NCT05443984,JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis,Onconic Therapeutics Inc.,['PHASE3'],False,COMPLETED,2023-01-05,2022-07-05,https://clinicaltrials.gov/study/NCT05443984,2023-01-05,0
NCT04780984,Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease,Nephron Pharmaceuticals Corporation,['PHASE2'],False,COMPLETED,2021-04-20,2021-03-04,https://clinicaltrials.gov/study/NCT04780984,2021-04-20,0
NCT04722484,"A Trial to Learn How Safe Vericiguat (BAY1021189) is and the Way the Body Absorbs, Distributes and Gets Rid of Vericiguat in Participants With Kidney Disease and in Age-, Weight- and Gender-matched Healthy Participants",Bayer,['PHASE1'],False,COMPLETED,2015-01-22,2021-01-25,https://clinicaltrials.gov/study/NCT04722484,2015-01-22,0
NCT05442684,A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine,CanSino Biologics Inc.,['PHASE3'],False,WITHDRAWN,2023-03-30,2022-07-05,https://clinicaltrials.gov/study/NCT05442684,2023-03-30,0
NCT06381284,Feasibility of Engaging and Capturing Undiagnosed Myasthenia Gravis Participants Through a Social Media Campaign Paired With a Self-moderated Assessment,ZS Associates,Unknown,False,RECRUITING,2024-05-27,2024-04-24,https://clinicaltrials.gov/study/NCT06381284,2024-05-27,0
NCT04961684,Clinical Evaluation of Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis,Oystershell NV,['NA'],False,COMPLETED,2020-09-22,2021-07-14,https://clinicaltrials.gov/study/NCT04961684,2020-09-22,0
NCT03087084,RESpiration deTection From Implanted Cardiac Devices in Subjects With Heart Failure (REST-HF),Medtronic BRC,['NA'],False,UNKNOWN,2020-04-01,2017-03-22,https://clinicaltrials.gov/study/NCT03087084,2020-04-01,0
NCT06337084,Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients with Solid Tumors,Monopar Therapeutics,['PHASE1'],False,RECRUITING,2025-04,2024-03-29,https://clinicaltrials.gov/study/NCT06337084,2025-04-01,0
NCT02772484,An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Routine Care,HeadSense Medical,['NA'],False,COMPLETED,2016-12,2016-05-13,https://clinicaltrials.gov/study/NCT02772484,2016-12-01,0
NCT02825784,A Multicenter Study to Evaluate the Nutritional Suitability of Renastart,"Vitaflo International, Ltd",['NA'],False,COMPLETED,2019-05-31,2016-07-07,https://clinicaltrials.gov/study/NCT02825784,2019-05-31,0
NCT06599684,Study of INV-102 Ophthalmic Solution in Adults With Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy,"Invirsa, Inc.",['PHASE2'],False,RECRUITING,2025-03,2024-09-19,https://clinicaltrials.gov/study/NCT06599684,2025-03-01,0
NCT05527184,"First in Human Study of IMGN151 in Recurrent Endometrial Cancer and Recurrent, High-grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers","ImmunoGen, Inc.",['PHASE1'],False,RECRUITING,2024-12-30,2022-09-02,https://clinicaltrials.gov/study/NCT05527184,2024-12-30,0
NCT04277884,Firibastat in Treatment-resistant Hypertension,Quantum Genomics SA,['PHASE3'],False,COMPLETED,2022-08-30,2020-02-20,https://clinicaltrials.gov/study/NCT04277884,2022-08-30,0
NCT06039384,A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation,Incyte Corporation,['PHASE1'],False,ACTIVE_NOT_RECRUITING,2025-11-03,2023-09-15,https://clinicaltrials.gov/study/NCT06039384,2025-11-03,0
NCT02262884,SurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study),"SurgiQuest, Inc.",['NA'],False,UNKNOWN,2016-12,2014-10-13,https://clinicaltrials.gov/study/NCT02262884,2016-12-01,0
NCT05375084,SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation,"Navire Pharma Inc., a BridgeBio company",['PHASE1'],False,RECRUITING,2024-07,2022-05-16,https://clinicaltrials.gov/study/NCT05375084,2024-07-01,0
NCT06572384,A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease,GlaxoSmithKline,['PHASE3'],False,RECRUITING,2028-10-18,2024-08-27,https://clinicaltrials.gov/study/NCT06572384,2028-10-18,0
NCT05190484,"bIosimilar of aDalimumab, an European evAluation",Fresenius Kabi,Unknown,False,UNKNOWN,2023-04-30,2022-01-13,https://clinicaltrials.gov/study/NCT05190484,2023-04-30,0
NCT05016284,Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis,"Applied Biology, Inc.",['PHASE3'],False,WITHDRAWN,2022-12-15,2021-08-23,https://clinicaltrials.gov/study/NCT05016284,2022-12-15,0
NCT05518084,Liponovo Tissue Product in Healthy Volunteers,Vesa Juutilainen,['EARLY_PHASE1'],False,UNKNOWN,2023-09-01,2022-08-26,https://clinicaltrials.gov/study/NCT05518084,2023-09-01,0
NCT05433584,A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes,Eli Lilly and Company,['PHASE4'],False,ACTIVE_NOT_RECRUITING,2025-10-30,2022-06-27,https://clinicaltrials.gov/study/NCT05433584,2025-10-30,1
NCT03473184,A 4-Day Study to Evaluate the Photoxicity of Diacerein 1% Topical Ointment in Healthy Volunteers,"Castle Creek Pharmaceuticals, LLC",['PHASE1'],True,COMPLETED,2017-12-15,2018-03-22,https://clinicaltrials.gov/study/NCT03473184,2017-12-15,0
NCT02609984,Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002),"Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",['PHASE2'],True,TERMINATED,2019-02-06,2015-11-20,https://clinicaltrials.gov/study/NCT02609984,2019-02-06,0
NCT04635384,Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test,CareDx,Unknown,False,ACTIVE_NOT_RECRUITING,2025-10-31,2020-11-19,https://clinicaltrials.gov/study/NCT04635384,2025-10-31,0
NCT02924584,"Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan",Pfizer,Unknown,False,COMPLETED,2017-02-28,2016-10-05,https://clinicaltrials.gov/study/NCT02924584,2017-02-28,0
NCT06628284,CGM As Diagnostic Tool in Observing Steroid-Induced Hyperglycemia,Mahesh Pattabiraman,Unknown,False,ENROLLING_BY_INVITATION,2025-03,2024-10-04,https://clinicaltrials.gov/study/NCT06628284,2025-03-01,0
NCT06555484,Acute Effects of Supplemental Oxygen on Memory Testing in Healthy Adult Volunteers,Inogen Inc.,['NA'],False,RECRUITING,2024-10,2024-08-15,https://clinicaltrials.gov/study/NCT06555484,2024-10-01,0
NCT02719184,Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease),Boehringer Ingelheim,Unknown,True,COMPLETED,2021-06-14,2016-03-25,https://clinicaltrials.gov/study/NCT02719184,2021-06-14,0
NCT03332784,Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy,Takeda,['PHASE1'],True,COMPLETED,2018-09-04,2017-11-06,https://clinicaltrials.gov/study/NCT03332784,2018-09-04,0
NCT02047084,Comparison of Human Allograft to Apligraf for Venous Leg Ulcers,Solsys Medical LLC,Unknown,False,ENROLLING_BY_INVITATION,2025-12-31,2014-01-28,https://clinicaltrials.gov/study/NCT02047084,2025-12-31,0
NCT04953884,"Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease VWD) Patients <6 Years of Age",Octapharma,['PHASE3'],False,ACTIVE_NOT_RECRUITING,2024-12,2021-07-08,https://clinicaltrials.gov/study/NCT04953884,2024-12-01,0
NCT06112184,Digital Health Program With Participants Using an Autoinjector,Sidekick Health,['NA'],False,RECRUITING,2024-04-01,2023-11-01,https://clinicaltrials.gov/study/NCT06112184,2024-04-01,0
NCT05489484,Performance and Safety Evaluation of MD-Shoulder Collagen Medical Device in the Treatment of Rotator Cuff Syndrome,Guna S.p.a,['NA'],False,RECRUITING,2025-01-29,2022-08-05,https://clinicaltrials.gov/study/NCT05489484,2025-01-29,0
NCT02011984,Multicentric Non-randomized Investigation of RESISTANT Camouflage Stent-system,Eucatech AG,Unknown,False,UNKNOWN,2016-03,2013-12-16,https://clinicaltrials.gov/study/NCT02011984,2016-03-01,0
NCT05947084,Comparison of Growth and Tolerance of Healthy Term Infants Fed Iron-Fortified Infant Formulas,"Aussie Bubs, Inc.",['PHASE3'],False,RECRUITING,2024-08-09,2023-07-17,https://clinicaltrials.gov/study/NCT05947084,2024-08-09,0
NCT01564784,A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia,Pfizer,['PHASE3'],True,COMPLETED,2016-03-08,2012-03-28,https://clinicaltrials.gov/study/NCT01564784,2016-03-08,0
NCT04862884,A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects,"Jiangsu HengRui Medicine Co., Ltd.",['PHASE1'],False,UNKNOWN,2021-09-03,2021-04-28,https://clinicaltrials.gov/study/NCT04862884,2021-09-03,0
NCT02088684,Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer,Novartis Pharmaceuticals,['PHASE1'],False,COMPLETED,2018-04-17,2014-03-17,https://clinicaltrials.gov/study/NCT02088684,2018-04-17,0
NCT05476484,Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma,ALK-Abelló A/S,Unknown,False,ACTIVE_NOT_RECRUITING,2024-06,2022-07-27,https://clinicaltrials.gov/study/NCT05476484,2024-06-01,0
NCT02333084,The Influence Of a Natural Anti-Inflammatory Product On Levels Of Inflammatory Markers In Cases With Osteoarthritis Of Knee,Physician Recommended Nutriceuticals,"['PHASE2', 'PHASE3']",False,UNKNOWN,2017-07,2015-01-07,https://clinicaltrials.gov/study/NCT02333084,2017-07-01,0
NCT02292784,Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies,GlaxoSmithKline,['PHASE3'],True,COMPLETED,2019-09-02,2014-11-17,https://clinicaltrials.gov/study/NCT02292784,2019-09-02,0
NCT03830684,"A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever","CSPC ZhongQi Pharmaceutical Technology Co., Ltd.",['PHASE2'],False,UNKNOWN,2019-05-31,2019-02-05,https://clinicaltrials.gov/study/NCT03830684,2019-05-31,0
NCT06522984,Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid,Egymedicalpedia,['NA'],False,RECRUITING,2025-06-01,2024-07-26,https://clinicaltrials.gov/study/NCT06522984,2025-06-01,0
NCT01451684,Development of a Non-invasive Prenatal Test,Cindy Cisneros,Unknown,False,COMPLETED,2019-12,2011-10-14,https://clinicaltrials.gov/study/NCT01451684,2019-12-01,0
NCT06604884,NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study,Medtronic Neurovascular Clinical Affairs,Unknown,False,NOT_YET_RECRUITING,2027-12,2024-09-20,https://clinicaltrials.gov/study/NCT06604884,2027-12-01,0
NCT04701684,WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment),Philips Clinical & Medical Affairs Global,['NA'],False,RECRUITING,2025-12-01,2021-01-08,https://clinicaltrials.gov/study/NCT04701684,2025-12-01,0
NCT03363984,Pharmacokinetic Interaction Between Midazolam and ID-082 in Healthy Subjects,Idorsia Pharmaceuticals Ltd.,['PHASE1'],False,COMPLETED,2017-12-19,2017-12-06,https://clinicaltrials.gov/study/NCT03363984,2017-12-19,0
NCT02385084,A Study of LY2409021 Formulations in Healthy Participants,Eli Lilly and Company,['PHASE1'],True,TERMINATED,2015-05,2015-03-11,https://clinicaltrials.gov/study/NCT02385084,2015-05-01,0
NCT05215184,Defense Health Agency- Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain,"PainQx, Inc",Unknown,False,COMPLETED,2022-08-30,2022-01-31,https://clinicaltrials.gov/study/NCT05215184,2022-08-30,0
NCT02739984,Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia,Amgen,['PHASE3'],True,COMPLETED,2017-08-03,2016-04-15,https://clinicaltrials.gov/study/NCT02739984,2017-08-03,0
NCT01646684,"Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate Cancer",Novartis Pharmaceuticals,['PHASE1'],False,COMPLETED,2018-11-13,2012-07-20,https://clinicaltrials.gov/study/NCT01646684,2018-11-13,0
NCT01668784,Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025),Bristol-Myers Squibb,['PHASE3'],True,COMPLETED,2015-05-06,2012-08-20,https://clinicaltrials.gov/study/NCT01668784,2015-05-06,0
NCT05700084,Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors,"Beijing Biostar Pharmaceuticals Co., Ltd.",['PHASE1'],False,RECRUITING,2025-03-09,2023-01-26,https://clinicaltrials.gov/study/NCT05700084,2025-03-09,0
NCT06645184,Adding Appetite Stimulants to an ONS in Older Adults,Nutricia Research,['NA'],False,NOT_YET_RECRUITING,2025-06,2024-10-16,https://clinicaltrials.gov/study/NCT06645184,2025-06-01,0
NCT02281084,Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes,Celgene,['PHASE2'],True,COMPLETED,2019-06-19,2014-11-02,https://clinicaltrials.gov/study/NCT02281084,2019-06-19,0
NCT03629184,"Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms",Hoffmann-La Roche,['PHASE3'],True,COMPLETED,2019-04-03,2018-08-14,https://clinicaltrials.gov/study/NCT03629184,2019-04-03,0
NCT05463484,"Effects of a Composition on the Oral Microbiome, pH, Nitrite/Nitrate Ratio, Elastases and Inflammation in Oral Dysbiosis","Mucosa Innovations, S.L.","['PHASE2', 'PHASE3']",False,COMPLETED,2023-02-28,2022-07-19,https://clinicaltrials.gov/study/NCT05463484,2023-02-28,0
NCT01898884,Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia,Shire,['PHASE1'],True,COMPLETED,2015-06-18,2013-07-15,https://clinicaltrials.gov/study/NCT01898884,2015-06-18,0
NCT06025084,The Effect of the Egg Shell Nanoparticles Combined With Titanium Dioxide Nanoparticles,Egymedicalpedia,['PHASE1'],False,COMPLETED,2023-03-15,2023-09-06,https://clinicaltrials.gov/study/NCT06025084,2023-03-15,0
NCT05124184,"Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access",W.L.Gore & Associates,Unknown,False,COMPLETED,2024-07-22,2021-11-17,https://clinicaltrials.gov/study/NCT05124184,2024-07-22,0
NCT06181084,A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants,Eli Lilly and Company,['PHASE1'],False,COMPLETED,2022-04-28,2023-12-26,https://clinicaltrials.gov/study/NCT06181084,2022-04-28,0
NCT04337684,Long Term Follow-up on Menkes Disease Patients,"Cyprium Therapeutics, Inc.",Unknown,False,ENROLLING_BY_INVITATION,2023-12-31,2020-04-08,https://clinicaltrials.gov/study/NCT04337684,2023-12-31,0
NCT04553484,Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.,Semler Scientific,Unknown,True,COMPLETED,2021-12-29,2020-09-17,https://clinicaltrials.gov/study/NCT04553484,2021-12-29,0
NCT03867084,Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937),Merck Sharp & Dohme LLC,['PHASE3'],False,ACTIVE_NOT_RECRUITING,2027-10-31,2019-03-07,https://clinicaltrials.gov/study/NCT03867084,2027-10-31,0
NCT05908084,To Compare the Efficacy and Safety of the HAV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis,"Humacyte, Inc.",['PHASE3'],False,RECRUITING,2026-10,2023-06-18,https://clinicaltrials.gov/study/NCT05908084,2026-10-01,0
NCT06678984,Treated Umbilical Vein Allograft (UVT) Versus Autologous Fascial Pubovaginal Sling in the Treatment of Female Stress Urinary Incontinence,TBF Genie Tissulaire,['PHASE3'],False,NOT_YET_RECRUITING,2028-01-01,2024-11-07,https://clinicaltrials.gov/study/NCT06678984,2028-01-01,0
NCT05060484,A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years,Sinocelltech Ltd.,['PHASE2'],False,UNKNOWN,2022-05-31,2021-09-29,https://clinicaltrials.gov/study/NCT05060484,2022-05-31,0
NCT01094184,A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer,Hoffmann-La Roche,['PHASE4'],True,COMPLETED,2015-12,2010-03-26,https://clinicaltrials.gov/study/NCT01094184,2015-12-01,1
NCT06467084,"Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) with HAE Type I or II","KalVista Pharmaceuticals, Ltd.",['PHASE3'],False,RECRUITING,2027-08-31,2024-06-20,https://clinicaltrials.gov/study/NCT06467084,2027-08-31,0
NCT02511184,Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients,Pfizer,['PHASE1'],True,TERMINATED,2017-12,2015-07-29,https://clinicaltrials.gov/study/NCT02511184,2017-12-01,0
NCT03774784,A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease,Alnylam Pharmaceuticals,Unknown,False,TERMINATED,2020-05-18,2018-12-13,https://clinicaltrials.gov/study/NCT03774784,2020-05-18,0
NCT03734484,Gram Type Infection-Specific Sepsis Identification Using Machine Learning,Dascena,['PHASE2'],False,WITHDRAWN,2022-11-30,2018-11-08,https://clinicaltrials.gov/study/NCT03734484,2022-11-30,0
NCT02128984,Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children,Laboratorios Ordesa,['NA'],False,COMPLETED,2015-02,2014-05-01,https://clinicaltrials.gov/study/NCT02128984,2015-02-01,0
NCT05573984,Natural History of PRPF31 Mutation-Associated Retinal Dystrophy,PYC Therapeutics,Unknown,False,RECRUITING,2026-12-31,2022-10-10,https://clinicaltrials.gov/study/NCT05573984,2026-12-31,0
NCT03817684,Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects,Tetra Discovery Partners,['PHASE2'],False,ACTIVE_NOT_RECRUITING,2020-02,2019-01-25,https://clinicaltrials.gov/study/NCT03817684,2020-02-01,0
NCT03829384,"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy Adults","ModernaTX, Inc.",['PHASE1'],False,COMPLETED,2021-06-07,2019-02-04,https://clinicaltrials.gov/study/NCT03829384,2021-06-07,0
NCT01696084,Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia,Jazz Pharmaceuticals,['PHASE3'],True,COMPLETED,2015-12-31,2012-09-28,https://clinicaltrials.gov/study/NCT01696084,2015-12-31,0
NCT04631484,International Trial of Efficacy of Cytoflavin in Head Trauma,POLYSAN Scientific & Technological Pharmaceutical Company,['PHASE3'],False,COMPLETED,2024-05-07,2020-11-17,https://clinicaltrials.gov/study/NCT04631484,2024-05-07,0
NCT02408484,"Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency",Octapharma,['PHASE3'],True,COMPLETED,2019-06-11,2015-04-03,https://clinicaltrials.gov/study/NCT02408484,2019-06-11,0
NCT05144984,A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes,Novo Nordisk A/S,['PHASE2'],False,COMPLETED,2023-02-13,2021-12-06,https://clinicaltrials.gov/study/NCT05144984,2023-02-13,0
NCT05579184,[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2,FutureChem,['PHASE2'],False,ACTIVE_NOT_RECRUITING,2024-12-31,2022-10-13,https://clinicaltrials.gov/study/NCT05579184,2024-12-31,0
NCT05034484,A Study of ALPN-303 in Adult Healthy Volunteers,"Alpine Immune Sciences, Inc.",['PHASE1'],False,COMPLETED,2023-02-27,2021-09-05,https://clinicaltrials.gov/study/NCT05034484,2023-02-27,0
NCT05455684,A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy,"Janssen Research & Development, LLC",['PHASE3'],False,RECRUITING,2024-09-18,2022-07-13,https://clinicaltrials.gov/study/NCT05455684,2024-09-18,0
NCT06613984,Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran),Pfizer,Unknown,False,ACTIVE_NOT_RECRUITING,2028-08-29,2024-09-26,https://clinicaltrials.gov/study/NCT06613984,2028-08-29,0
NCT06269484,A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK,AstraZeneca,['PHASE2'],False,RECRUITING,2025-01-17,2024-02-21,https://clinicaltrials.gov/study/NCT06269484,2025-01-17,0
NCT06236984,Retrospective Data Analysis of CKRT (Continuous Kidney Replacement Therapy) Treatments in Adult Mode with MultiFiltratePRO,Fresenius Medical Care Deutschland GmbH,Unknown,False,RECRUITING,2024-12,2024-02-01,https://clinicaltrials.gov/study/NCT06236984,2024-12-01,0
NCT03441984,To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers,ViiV Healthcare,['PHASE1'],True,COMPLETED,2018-04-28,2018-02-22,https://clinicaltrials.gov/study/NCT03441984,2018-04-28,0
NCT06084884,A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma,AstraZeneca,"['PHASE1', 'PHASE2']",False,RECRUITING,2027-12-13,2023-10-16,https://clinicaltrials.gov/study/NCT06084884,2027-12-13,0
NCT04075084,Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs),Biotronik SE & Co. KG,Unknown,False,RECRUITING,2027-09-30,2019-08-30,https://clinicaltrials.gov/study/NCT04075084,2027-09-30,0
NCT01584284,Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer,Genelux Corporation,['PHASE1'],False,COMPLETED,2015-06,2012-04-24,https://clinicaltrials.gov/study/NCT01584284,2015-06-01,0
NCT03742284,Safety and Performance of SoftOx Wound Irrigation Solution (SWIS) in Acute Wounds,SoftOx Solutions AS,['NA'],False,UNKNOWN,2019-05-31,2018-11-15,https://clinicaltrials.gov/study/NCT03742284,2019-05-31,0
NCT04569084,Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS,Mitsubishi Tanabe Pharma America Inc.,['PHASE3'],False,TERMINATED,2023-09-29,2020-09-29,https://clinicaltrials.gov/study/NCT04569084,2023-09-29,0
NCT01870284,Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS),Eli Lilly and Company,['PHASE3'],False,WITHDRAWN,2016-04,2013-06-06,https://clinicaltrials.gov/study/NCT01870284,2016-04-01,0
NCT02565784,Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population,Galderma R&D,['NA'],True,COMPLETED,2016-12-29,2015-10-01,https://clinicaltrials.gov/study/NCT02565784,2016-12-29,0
NCT03135184,HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia,HDL Therapeutics,['NA'],False,UNKNOWN,2019-01-07,2017-05-01,https://clinicaltrials.gov/study/NCT03135184,2019-01-07,0
NCT02927184,Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease,"Viking Therapeutics, Inc.",['PHASE2'],False,COMPLETED,2019-03-26,2016-10-06,https://clinicaltrials.gov/study/NCT02927184,2019-03-26,0
NCT05047484,A Study of Multiple Doses of ALXN2050 in Healthy Adults,"Alexion Pharmaceuticals, Inc.",['PHASE1'],False,COMPLETED,2019-07-23,2021-09-17,https://clinicaltrials.gov/study/NCT05047484,2019-07-23,0
NCT04718584,the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors,Dragonboat Biopharmaceutical Company Limited,['PHASE2'],False,UNKNOWN,2022-11,2021-01-22,https://clinicaltrials.gov/study/NCT04718584,2022-11-01,0
NCT04830384,Evaluation of LLLT/Music for Smoking Cessation,"Freedom Laser, Inc.",['NA'],False,COMPLETED,2020-11-01,2021-04-05,https://clinicaltrials.gov/study/NCT04830384,2020-11-01,0
NCT02174484,Assessment of Intracardiac Electrograms Transmitted by Home Monitoring for the Remote Follow-up of Pacemaker (PREMS),Biotronik SE & Co. KG,Unknown,False,COMPLETED,2015-12,2014-06-25,https://clinicaltrials.gov/study/NCT02174484,2015-12-01,0
NCT06346184,A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers,Hanmi Pharmaceutical Company Limited,['PHASE1'],False,COMPLETED,2024-06-10,2024-04-03,https://clinicaltrials.gov/study/NCT06346184,2024-06-10,0
NCT05199584,A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations,"Endeavor Biomedicines, Inc.",['PHASE2'],False,ACTIVE_NOT_RECRUITING,2024-05,2022-01-20,https://clinicaltrials.gov/study/NCT05199584,2024-05-01,0
NCT06441084,A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation,"Nuwacell Biotechnologies Co., Ltd.",['PHASE1'],False,NOT_YET_RECRUITING,2028-12-31,2024-06-04,https://clinicaltrials.gov/study/NCT06441084,2028-12-31,0
NCT02002884,Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy,Merz Pharmaceuticals GmbH,['PHASE3'],True,COMPLETED,2017-07-04,2013-12-06,https://clinicaltrials.gov/study/NCT02002884,2017-07-04,0
NCT02339584,Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT),Alcon Research,['PHASE3'],True,COMPLETED,2016-11-01,2015-01-15,https://clinicaltrials.gov/study/NCT02339584,2016-11-01,0
NCT06118684,Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin,EpiEndo Pharmaceuticals,['PHASE1'],False,COMPLETED,2024-01-02,2023-11-07,https://clinicaltrials.gov/study/NCT06118684,2024-01-02,0
NCT02035384,Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A,Novo Nordisk A/S,Unknown,False,COMPLETED,2020-01-15,2014-01-14,https://clinicaltrials.gov/study/NCT02035384,2020-01-15,0
NCT04376684,Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease,GlaxoSmithKline,['PHASE2'],True,COMPLETED,2021-07-15,2020-05-06,https://clinicaltrials.gov/study/NCT04376684,2021-07-15,0
NCT05089084,Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS),Arrowhead Pharmaceuticals,['PHASE3'],False,ACTIVE_NOT_RECRUITING,2024-04-29,2021-10-22,https://clinicaltrials.gov/study/NCT05089084,2024-04-29,0
NCT05497284,To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF,Novartis Pharmaceuticals,['PHASE2'],False,TERMINATED,2024-08-26,2022-08-11,https://clinicaltrials.gov/study/NCT05497284,2024-08-26,0
NCT05854784,Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP),Clinuvel (UK) Ltd.,['PHASE2'],False,COMPLETED,2023-12-28,2023-05-11,https://clinicaltrials.gov/study/NCT05854784,2023-12-28,0
NCT05464784,"MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia",MediciNova,['PHASE2'],False,RECRUITING,2025-12-31,2022-07-19,https://clinicaltrials.gov/study/NCT05464784,2025-12-31,0
NCT03444584,Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes,MedImmune LLC,['PHASE2'],True,COMPLETED,2018-12-06,2018-02-23,https://clinicaltrials.gov/study/NCT03444584,2018-12-06,0
NCT03785184,A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy,AbbVie,['PHASE2'],False,WITHDRAWN,2019-08-22,2018-12-24,https://clinicaltrials.gov/study/NCT03785184,2019-08-22,0
NCT02448784,Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).,"Eisai Co., Ltd.",Unknown,False,COMPLETED,2017-03-30,2015-05-19,https://clinicaltrials.gov/study/NCT02448784,2017-03-30,0
NCT01984684,Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections,"Melinta Therapeutics, Inc.",['PHASE3'],True,COMPLETED,2015-12,2013-11-15,https://clinicaltrials.gov/study/NCT01984684,2015-12-01,0
NCT04420884,A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors,Takeda,"['PHASE1', 'PHASE2']",False,RECRUITING,2026-01-15,2020-06-09,https://clinicaltrials.gov/study/NCT04420884,2026-01-15,0
NCT02700984,A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial,Alcon Research,['NA'],True,COMPLETED,2018-04-18,2016-03-07,https://clinicaltrials.gov/study/NCT02700984,2018-04-18,0
NCT02326584,A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML,Seagen Inc.,['PHASE1'],False,COMPLETED,2017-01-30,2014-12-29,https://clinicaltrials.gov/study/NCT02326584,2017-01-30,0
NCT01374984,VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection,Emergent BioSolutions,Unknown,False,ENROLLING_BY_INVITATION,2025-08,2011-06-17,https://clinicaltrials.gov/study/NCT01374984,2025-08-01,0
NCT04793984,Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients,Marinomed Biotech AG,['NA'],False,COMPLETED,2022-07-30,2021-03-11,https://clinicaltrials.gov/study/NCT04793984,2022-07-30,0
NCT05193084,Remote Monitoring of Ambulatory Intravenous Diuretics in Heart Failure,Heartfelt Technologies,Unknown,False,ACTIVE_NOT_RECRUITING,2024-01-14,2022-01-14,https://clinicaltrials.gov/study/NCT05193084,2024-01-14,0
NCT04792684,Collection of Samples USOPTIVAL Study,Universal Diagnostics,Unknown,False,RECRUITING,2024-12-30,2021-03-11,https://clinicaltrials.gov/study/NCT04792684,2024-12-30,0
NCT04702984,Clinical Characterization of an Investigational Frequent Replacement Daily Wear Silicone Hydrogel Sphere Contact Lens,Alcon Research,['NA'],True,COMPLETED,2021-02-26,2021-01-11,https://clinicaltrials.gov/study/NCT04702984,2021-02-26,0
NCT04466384,Bispectral Index and Levels of Sedation With Propofol With/Without Remifentanil in Healthy Volunteers (SONORA),Medtronic - MITG,['NA'],True,COMPLETED,2021-03-03,2020-07-10,https://clinicaltrials.gov/study/NCT04466384,2021-03-03,0
NCT03536884,A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis,UCB Biopharma SRL,['PHASE3'],True,COMPLETED,2019-09-12,2018-05-25,https://clinicaltrials.gov/study/NCT03536884,2019-09-12,0
NCT04090684,Ciprofloxacin/Celecoxib Combination in Patients With ALS,NeuroSense Therapeutics Ltd.,['PHASE1'],False,COMPLETED,2021-09-27,2019-09-16,https://clinicaltrials.gov/study/NCT04090684,2021-09-27,0
NCT05083884,A Survey About Hot Flashes in Women Going Through the Menopause,Astellas Pharma Europe Ltd.,Unknown,False,COMPLETED,2022-01-17,2021-10-19,https://clinicaltrials.gov/study/NCT05083884,2022-01-17,0
NCT04026984,Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years,RedHill Biopharma Limited,['PHASE2'],False,NOT_YET_RECRUITING,2025-06,2019-07-19,https://clinicaltrials.gov/study/NCT04026984,2025-06-01,0
NCT03718884,A Study of Mirikizumab in Participants With Plaque Psoriasis,Eli Lilly and Company,['PHASE1'],True,COMPLETED,2019-10-28,2018-10-25,https://clinicaltrials.gov/study/NCT03718884,2019-10-28,0
NCT06498284,Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus,Hua Medicine Limited,['PHASE1'],False,RECRUITING,2024-07-23,2024-07-12,https://clinicaltrials.gov/study/NCT06498284,2024-07-23,0
NCT05377684,Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment,Ipsen,Unknown,False,RECRUITING,2026-03-31,2022-05-17,https://clinicaltrials.gov/study/NCT05377684,2026-03-31,0
NCT01351584,Tumour Registry Breast Cancer,iOMEDICO AG,Unknown,False,COMPLETED,2021-12,2011-05-11,https://clinicaltrials.gov/study/NCT01351584,2021-12-01,0
NCT06541184,Ziconotide for Non-cancer Pain by Intrathecal Administration,ESTEVE Pharmaceuticals SAS,Unknown,False,NOT_YET_RECRUITING,2029-09-15,2024-08-07,https://clinicaltrials.gov/study/NCT06541184,2029-09-15,0
NCT03137784,Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma,Novartis Pharmaceuticals,"['PHASE2', 'PHASE3']",True,COMPLETED,2017-12-29,2017-05-03,https://clinicaltrials.gov/study/NCT03137784,2017-12-29,0
NCT06259084,Study to Estimate Seedchrony's Predictive Capacity in the Success of Embryo Implantation.,Manina Medtech,['NA'],False,RECRUITING,2025-02-05,2024-02-14,https://clinicaltrials.gov/study/NCT06259084,2025-02-05,0
NCT03196284,A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors,Novo Nordisk A/S,['PHASE2'],True,COMPLETED,2018-09-19,2017-06-22,https://clinicaltrials.gov/study/NCT03196284,2018-09-19,0
NCT05984784,"A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)",Inmagene LLC,"['PHASE1', 'PHASE2']",False,TERMINATED,2024-04-26,2023-08-09,https://clinicaltrials.gov/study/NCT05984784,2024-04-26,0
NCT05082584,Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents,Akebia Therapeutics,['PHASE3'],False,SUSPENDED,2026-07,2021-10-19,https://clinicaltrials.gov/study/NCT05082584,2026-07-01,0
NCT04927884,A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies,"ImmunityBio, Inc.","['PHASE1', 'PHASE2']",True,TERMINATED,2022-09-13,2021-06-16,https://clinicaltrials.gov/study/NCT04927884,2022-09-13,0
NCT04939584,Patient Perception of MultiPulse Therapy™ (MPT™),"Cardialen, Inc.",['NA'],False,TERMINATED,2022-10-01,2021-06-25,https://clinicaltrials.gov/study/NCT04939584,2022-10-01,0
NCT06517784,Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian HCPs & Patients With Type 2 Diabetes,Novo Nordisk A/S,Unknown,False,COMPLETED,2024-08-16,2024-07-24,https://clinicaltrials.gov/study/NCT06517784,2024-08-16,0
NCT05170984,MAtrix Therapy for Hard-to-heal ChrOnic Wounds,"Organ, Tissue, Regeneration, Repair and Replacement",['NA'],False,RECRUITING,2024-07,2021-12-28,https://clinicaltrials.gov/study/NCT05170984,2024-07-01,0
NCT02221284,"Alogliptin Tablets Specified Drug-use Survey ""Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)""",Takeda,Unknown,True,COMPLETED,2017-06-30,2014-08-20,https://clinicaltrials.gov/study/NCT02221284,2017-06-30,0
NCT04999384,"First in Human, Dose Escalation Study of AN4005","Adlai Nortye Biopharma Co., Ltd.",['PHASE1'],False,RECRUITING,2025-08,2021-08-10,https://clinicaltrials.gov/study/NCT04999384,2025-08-01,0
NCT04071184,Study of Alofanib in Patients With Metastatic Gastric Cancer,Russian Pharmaceutical Technologies,['PHASE1'],False,UNKNOWN,2020-10-01,2019-08-28,https://clinicaltrials.gov/study/NCT04071184,2020-10-01,0
NCT04791384,Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer,"Criterium, Inc.","['PHASE1', 'PHASE2']",False,RECRUITING,2024-12,2021-03-10,https://clinicaltrials.gov/study/NCT04791384,2024-12-01,0
